betamethasone has been researched along with Psoriasis in 629 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 252 (40.06) | 18.7374 |
| 1990's | 45 (7.15) | 18.2507 |
| 2000's | 88 (13.99) | 29.6817 |
| 2010's | 148 (23.53) | 24.3611 |
| 2020's | 96 (15.26) | 2.80 |
| Authors | Studies |
|---|---|
| Calzavara-Pinton, P; de la Cueva, P; Gooderham, M; Jalili, A; Kircik, L; Lons-Danic, D; Nyholm, N; Petersen, B; Pink, A; Segaert, S; Thaçi, D; Thoning, H; Tyring, S | 1 |
| Augustin, M; Gold, LS; Green, LJ; Pinter, A; Praestegaard, M; Selmer, J | 1 |
| Calzavara-Pinton, P; Dapavo, P; De Simone, C; Fabbrocini, G; Malagoli, P; Martella, A | 1 |
| Damsky, W; Murphy, MJ; Vesely, MD | 1 |
| Ou, J; Zhang, J | 1 |
| Frątczak, A; Lis-Święty, A | 1 |
| Bagel, J; Nelson, E | 1 |
| Armstrong, A; Koo, J; Pinter, A; Præstegaard, M; Reich, A; Selmer, J | 1 |
| Guenther, L; Levin, LÅ; Megna, M; Nyholm, N; Sebastian, M; Takhar, A; Thoning, H | 1 |
| Cacciapuoti, S; Fabbrocini, G; Gallo, L; Ruggiero, A | 1 |
| Chasapi, V; Cheliotis, G; Georgiou, S; Ioannides, D; Lazaridou, E; Papadavid, E; Rigopoulos, D; Sfaelos, K | 3 |
| Abdulla, SJ; Adam, DN; Ashkenas, J; Fleming, P; Gooderham, MJ; McCracken, CB | 1 |
| Kircik, L; Ozyurekoglu, E | 1 |
| Abdallah, M; El-Gazayerly, O; Shalaby, RA | 1 |
| Amoruso, GF; Baglieri, F; Biamonte, AS; Bianchelli, T; Bigi, L; Bortoli, J; Brunetti, B; Buligan, C; Cagni, E; Calderoni, O; Calzavara-Pinton, P; Campanati, A; Campione, E; Caputo, A; Carrera, CG; Carugno, A; Chersi, K; Cicchelli, S; Dapavo, P; De Natale, F; De Simone, C; Di Maria, D; Errichetti, E; Fabbrocini, G; Ferrari, AS; Fogli, E; Forconi, R; Franchi, C; Galeazzi, A; Gambardella, A; Giovannini, A; Giura, MT; Iuculano, M; Lazzaretti, G; Leporati, C; Magnanini, M; Malagoli, P; Marconi, B; Martella, A; Maruccia, A; Megna, M; Miglietta, R; Minuti, A; Mocci, L; Modica, S; Narcisi, A; Odorici, G; Osti, F; Pazzaglia, M; Peila, R; Pertusi, G; Pezza, M; Pezzullo, E; Puccia, N; Raulo, U; Ribero, S; Rossi, M; Rusignuolo, S; Sapienza, G; Savarese, C; Scalisi, M; Strippoli, D; Stroppiana, E; Tiberio, R; Trischitta, A; Tucci, MG; Vaira, F; Verrone, A; Villa, L; Zagni, F; Zagni, G; Zoccali, A | 1 |
| Feldman, SR; Singh, R; Taylor, A | 1 |
| Bang, CH; Jeong, KH; Jo, SJ; Kim, BS; Kim, DH; Lee, JH; Park, CJ; Park, HJ; Shin, BS; Song, HJ; Youn, SW | 1 |
| Abdullah, M; Ahmad, A; Ahmed, M; Anjum, S; Nadeem, R; Rashid, S; Shah, SAA; Ul-Haq, Z; Zia, K | 1 |
| Czerwińska, J; Kasprowicz-Furmańczyk, M; Owczarczyk-Saczonek, A; Placek, W | 1 |
| Ghafoor, R; Goldust, M; Grabbe, S; Kircik, L; Patil, A; Weinberg, J; Yamauchi, P | 1 |
| Avey, B; Baker, H; Barker, E; Bewley, A; Galván, J; Green, W; Pi-Blanque, A; Praestegaard, M; Trebbien, P | 1 |
| Cardot-Leccia, N; Duteil, L; Heim, M; Irondelle, M; Passeron, T; Rocchi, S; Tulic, MK | 1 |
| Bourlioux, M; Fuchs, CSK; Haedersdal, M; Mandel, VD; Nissen, CV; Ortner, VK; Philipsen, PA; Skak, K; Zibert, JR | 1 |
| Collier, MR; Devjani, S; Egeberg, A; Oulee, A; Smith, B; Wu, JJ | 1 |
| Bewley, A; van de Kerkhof, P | 1 |
| Pinter, A; van de Kerkhof, P | 1 |
| Armstrong, AW; Augustin, M; Danø, A; Dhawan, S; Galván, J; Gold, LS; Green, LJ; Pinter, A; Praestegaard, M; Reich, A; Selmer, J; Stallknecht, SE; Trebbien, P | 1 |
| Beveridge, AJ; Perry, R; Rasmussen, ER; Sears, AJ | 1 |
| Hutt, HJ; Staubach, P; von Kiedrowski, R; Wurzer, E | 1 |
| Alexis, A; Cices, A; Kaufman, B; Liu, J; Sanabria-Gonzalez, I | 1 |
| Abdel Raouf, NM; El Sharkawy, DA; El-Komy, MHM; Fahim, A; Sobhi, RM | 1 |
| Hou, YL; Lin, SH | 1 |
| Bhatia, N; Callender, VD; Curcio, A; Feldman, SR; Gorodokin, B; Kircik, L; Kontzias, CL; Tissera, KA | 1 |
| Arenberger, P; Armstrong, A; Augustin, M; Gold, LS; Iversen, L; Pinter, A; Praestegaard, M; Reich, A | 1 |
| Armstrong, AW; Khan, S; Kircik, L; Reddy, R | 1 |
| Cui, J; Deng, H; Deng, J; Han, L; Lu, C; Yan, Y; Yao, D; Ye, S; Yu, J; Yu, X; Zhang, X | 1 |
| Armstrong, AW; Kircik, L; Lee, K | 1 |
| Gasparini, S; Giovene, GL; Martella, A; Papa, S | 1 |
| Grabnar Peklar, D; Habjanič, N; Kerec-Kos, M; Lužar-Stiffler, V | 1 |
| Eichenfield, LF; Kurvits, M; Liljedahl, M; Marcoux, D | 1 |
| Fukaya, S; Fukuyasu, A; Hau, CS; Hayashi, K; Ishikawa, T; Kamata, M; Ohnishi, T; Shimizu, T; Tada, Y; Takeoka, S; Tanaka, T | 1 |
| Bennardo, L; Bianchi, L; Dastoli, S; Dattola, A; Nisticò, SP; Passante, M; Patruno, C; Rizzuto, F; Silvestri, M | 1 |
| Antunes, J; Balak, DMW; Becla, L; Bewley, A; Calzavara-Pinton, P; Carrascosa, JM; Gregoriou, S; Nyeland, ME; Sawyer, LM; Viola, MG | 1 |
| Gerdes, S; Hubo, M; Velasco, M; Veverka, KA; Wu, JJ | 1 |
| Habjanič, N; Kerec Kos, M; Kristan, K | 1 |
| Abramovits, W; Hoejen, MN; Liljedahl, M; Seyger, M; Teng, J | 1 |
| Agbo-Godeau, S; Bernard, P; Boralevi, F; Francès, C; Fricain, JC; Le Gouge, A; Leducq, S; Pascal, F; Passeron, T; Samimi, M; Vaillant, L | 1 |
| Anger, T; Del Rosso, J; Hansen, B; Kircik, LH; Patel, DS; Veverka, KA | 1 |
| Feldman, SR; Haidari, W; Pona, A | 1 |
| Allenby, K; Bagel, J; Sidgiddi, S; Stein Gold, L | 1 |
| Akiyama, M; Ando, Y; Ohshima, Y; Takama, H; Watanabe, D; Yanagishita, T | 1 |
| Gregoriou, S; Kostakis, P; Panagakis, P; Polydorou, D; Rigopoulos, D; Rompoti, N; Sidiropoulou, P; Tsimpidakis, A; Tsironi, T | 1 |
| Chen, H; Gu, J; Li, M; Liu, X; Lou, D; Sun, J; Sun, Q; Wen, H; Yang, H; Zhang, J | 1 |
| Alejo, B; Domínguez, M; Ertekin, SS; Herrero, A; Iglesias, P; Malvehy, J; Martinez, N; Puig, S; Villa-Crespo, L; Yélamos, O; Zamora-Barquero, S | 1 |
| Bewley, A; Dauden, E; Fabbrocini, G; Jalili, A | 1 |
| Gold, LS; Hansen, JB; Patel, D; Strober, B; Veverka, KA | 1 |
| Du, YZ; Huang, QL; Lu, KJ; Qi, J; Shu, GF; Sun, MC; Tan, WQ; Wang, W; Xu, XL | 1 |
| Camela, E; Cinelli, E; Fabbrocini, G; Megna, M | 1 |
| Bianchi, L; Dattola, A; Ferrari, D; Floris, R; Guazzaroni, M; Lamacchia, F; Marisi, V; Marsico, S; Orlacchio, A; Tatulli, D | 1 |
| Hagiwara, M; Katayama, H; Koda, M; Matsuo, K; Nakagawa, H; Sasaki, H; Takahashi, H; Tanito, K; Uwajima, Y | 1 |
| Ewing, I; Gananandan, K; Sacks, B | 1 |
| Ashizawa, S; Hide, M; Takahagi, S; Tanaka, A | 1 |
| Lebwohl, M; Petersen, B | 1 |
| Alonso-Llamazares, J; Cantrell, W; Kircik, L; Koo, J; Moore, A; Stein Gold, L; Teng, J | 1 |
| Gold, LS; Kircik, L; Lacour, JP; Lebwohl, M; Liljedahl, M; Lynde, C; Mørch, MH; Papp, KA; Perrot, JL; Takhar, A; Thaçi, D; Warren, RB; Wollenberg, A | 1 |
| Kircik, LH; Schlesinger, TE; Tanghetti, E | 1 |
| Abramovits, W; Gupta, AK; Teng, JMC; Vincent, KD | 1 |
| Hansen, JB; Nyholm, N; Patel, DS; Swensen, AR; Veverka, KA; Wu, JJ | 1 |
| Ayyagari, R; Glick, B; Guerin, A; Jacobson, A; Joseph, G; Kircik, L; Lin, T | 1 |
| Cao, S; Chen, K; Chen, Y; Cheng, H; Ding, Y; Fang, H; Han, X; He, L; He, Y; Huang, J; Li, M; Li, S; Li, W; Liu, L; Lu, Q; Lu, Y; Pan, W; Wang, J; Yan, G; Zhang, C; Zhang, J; Zheng, M; Zhu, W | 1 |
| Di Guida, A; Fabbrocini, G; Napolitano, M; Patruno, C | 1 |
| Bagel, J; Hetzel, A; Nelson, E; Riley, C | 1 |
| Chen, H; Diao, Q; Gao, Y; Geng, L; He, C; He, Y; Hu, F; Ji, C; Jin, H; Jing, H; Li, L; Li, X; Li, Y; Liu, X; Lu, Q; Lu, T; Lv, C; Miao, G; Shi, J; Shi, Y; Song, J; Wang, R; Wang, X; Wang, Y; Xia, J; Xia, X; Yan, M; Yang, X; Zhang, L; Zhang, R; Zhang, S; Zhang, X; Zheng, M; Zhou, X | 1 |
| Foist, M; Mahe, E; Moumane, SH | 1 |
| Lebwohl, M; Thaçi, D; Warren, RB | 1 |
| Paul, C; Romiti, R; Stein Gold, L | 1 |
| Jalili, A; Yosipovitch, G | 1 |
| Iversen, L; Koo, J; Tada, Y | 1 |
| Armstrong, A; Gerdes, S | 1 |
| Lebwohl, M; Warren, RB | 1 |
| Balogh, EA; Feldman, SR; Heron, CE; Purvis, CG | 1 |
| Artzi, O; Ellenbogen, E; Matz, H; Shehadeh, W; Sprecher, E | 1 |
| Dhawan, S; Green, LJ; Praestegaard, M; Selmer, J; Stein Gold, L; Vestbjerg, B | 1 |
| Gold, M; Gooderham, M; Kircik, LH; Lacour, JP; Laws, P; Liljedahl, M; Lynde, C; Mørch, MH; Sondermann, W; Thaçi, D; Warren, RB | 1 |
| Nyholm, N; Petersen, B; Stein Gold, L; Takhar, A; Thoning, H | 1 |
| Bark, C; Brown, C; Svangren, P | 1 |
| Asahina, A; Asawanonda, P; Frez, ML; Hyun Kim, D; Imafuku, S; Theng, C; Wang, L; Zhang, JA; Zhao, Y; Zimmo, S | 1 |
| Alić, A; Elez-Burnjaković, N; Hadžić, M; Haverić, A; Haverić, S; Lojo-Kadrić, N; Mujezinović, I; Pojskić, L; Ramić, J; Smajlović, A | 1 |
| Gooderham, M; Harvima, RJ; Nyholm, N; Stein Gold, L; Thoning, H; Tyring, S | 1 |
| Argenziano, G; Atzori, L; Bianchi, L; Campanati, A; Corazza, M; Damiani, G; De Pità, O; Donini, M; Fargnoli, MC; Feliciani, C; Mazzatenta, C; Mazzotta, A; Offidani, A; Peris, K; Potenza, C; Prignano, F; Stingeni, L; Tiberio, R | 1 |
| Abdel Hamid, HF; Amin, MA; Attia, SS; El-Nefiawy, NE; Fetouh, MA; Rafla, M | 1 |
| Adamski, Z; Guenther, L; Lacour, JP; Liljedahl, M; Lynde, C; Miasik-Pogodzinska, A; Mørch, MH; Nutt, T; Papp, K; Reich, A; Sadick, N; Szponar-Bojda, A; Turchin, I; Tyring, S; Werschler, W | 1 |
| Hansen, JB; Kircik, L; Stein Gold, L; Veverka, KA; Yaloumis, M | 1 |
| Ding, H; Dong, S; Feng, J; Li, N; Li, X; Ren, J; Sun, Z; Wang, H; Wang, S; Zhu, Q | 1 |
| Croney, S | 1 |
| Iizuka, H; Satoh, K; Takagi, A; Takahashi, H | 1 |
| Ansaripour, A; Maessen, R; Redekop, WK; Thio, HB | 1 |
| Caldarola, G; De Simone, C; Moretta, G; Peris, K; Poscia, A | 1 |
| Chantzaras, A; Kontodimas, S; Yfantopoulos, J | 1 |
| Asche, CV; Feldman, SR; Kim, M; Lu, M; Zografos, P | 1 |
| Frieder, J; Kivelevitch, D; Menter, A | 1 |
| Hägg, PM; Kubin, ME; Pääkkö, TJW; Palatsi, R; Tasanen, K | 1 |
| Borghi, A; Conti, A; Gisondi, P; Manfredini, S; Pazzaglia, M; Piaserico, S; Stinco, G; Venturini, M | 1 |
| Bulai Livideanu, C; Kaldate, R; Paul, C; Røpke, M; Snel, A | 1 |
| Hong, CH; Lophaven, KW; Papp, KA; Philipp, S; Skallerup, P | 2 |
| Goldenberg, G; Hashim, PW; Kircik, LH; Nia, JK; Terrano, D | 1 |
| Ikumi, K; Kubo, R; Morita, A; Muramatsu, S; Nishida, E; Sagawa, Y; Saito, C; Torii, K | 1 |
| Barker, RN; Kotb, IS; Lewis, BJ; Ormerod, AD | 1 |
| Foley, P; Garrett, S; Ryttig, L | 1 |
| Cardis, MA; Moshell, AN | 1 |
| Araújo, MM; Arruda, C; Carvalho, T; Marcato, PD; Pivetta, TP; Simões, S | 1 |
| Andersen, F; Andersen, KE; Andersen, KH; Svendsen, MT | 1 |
| Anger, T; Gerdes, S; Hutt, HJ; Körber, A; Krakor, M | 1 |
| Andersen, F; Andersen, KE; Andersen, KH; August, B; Feldman, SR; Johannessen, H; Möller, S; Pottegård, A; Svendsen, MT | 1 |
| Grabnar-Peklar, D; Habjanic, N; Kerec-Kos, M; Koytchev, R; Yankova, R | 1 |
| Cambazard, F; Griffiths, CE; Kalb, RE; Lowson, D; Møller, A; Paul, C; Stein Gold, L | 1 |
| Carretero, G; Puig, L | 1 |
| Adamski, Z; Bowszyc-Dmochowska, M; Dańczak-Pazdrowska, A; Gaura, T; Olek-Hrab, K; Osmola-Mańkowska, A; Polańska, A; Żaba, R | 1 |
| Kuehl, B; Shear, NH | 1 |
| Bagel, J; Nelson, E; Zapata, J | 1 |
| Cantrell, W; Gooding, K; Gorelick, J; Kucera, K; Veverka, KA | 1 |
| Fu, L; Gao, XH; Jin, H; Li, R; Li, X; Lin, Z; Liu, Y; Lu, Q; Wang, Y; Xia, L; Xiao, F; Yang, S; Zhang, J; Zhang, X; Zheng, J | 1 |
| Giacomelli, L; Giovene, GL | 1 |
| Bewley, AP; Calzavara-Pinton, PG; Hansen, JB; Nyeland, ME; Shear, NH; Signorovitch, J | 1 |
| Andersen, SB; Berg, P; Calzavara-Pinton, PG; de la Cueva Dobao, P; Jalili, A; Jensen, KL; Lebwohl, M; Pink, AE; Segaert, S; Stein Gold, L; Thaçi, D | 1 |
| Duvetorp, A; Engerstedt Mattsson, E; Levin, LÅ; Ryttig, L | 1 |
| Lee, EB; Pithadia, DJ; Reynolds, KA; Wu, JJ | 1 |
| Andersen, KE; Feldman, SR; Möller, S; Svendsen, MT | 1 |
| Balato, A; Caterino, P; Cirillo, T; Dente, V; Gallo, L; Lodi, G; Megna, M; Mozzillo, R | 1 |
| Berg, P; Calzavara-Pinton, PG; de la Cueva Dobao, P; Jalili, A; Jensen, KL; Pink, AE; Segaert, S; Thaçi, D; Torpet, M | 1 |
| Del Rosso, JQ; Kircik, LH | 1 |
| Deng, H; Deng, J; Lu, C; Wen, Z; Xiang, Y; Xuan, M; Yan, Y; Yao, D | 1 |
| González-Fernández, D; Pérez-Barrio, S; Rodriguez-Martín, M; Sánchez-Regaña, M; Velasco, M | 1 |
| Anger, T; Eicke, C; Sticherling, M | 1 |
| Hendriks, AG; Hondebrink, E; Seyger, MM; Steenbergen, W; van de Kerkhof, PC; van Hespen, JC | 1 |
| Agozzino, M; Ardigò, M; Berardesca, E; Conti, A; Di Lernia, V; Longo, C; Pellacani, G | 1 |
| Calvieri, S; Camplone, G; Chimenti, S; D'Agostino, M; De Simone, C; Di Cesare, A; Filosa, G; Frascione, P; Gabellini, M; Lunghi, F; Mazzotta, A; Peris, K; Saraceno, R; Scotto Di Luzio, G; Simonacci, M | 1 |
| Bäumer, W; Dickhaut, J; Japtok, L; Kietzmann, M; Kleuser, B; Mischke, R; Schaper, K | 1 |
| Bachelez, H; Bagot, M; Cavelier-Balloy, B; Dauendorffer, JN | 1 |
| Höpfl, R; Huemer, HP; Martini, K; Müller, H | 1 |
| Abdelmaksood, R; Hashad, D | 1 |
| Clonier, F; Gupta, AK; Leeder, R; Olesen, M; Silver, S; Taraska, V; Tuppal, R | 1 |
| Ahn, CS; Awadalla, F; Dabade, TS; Feldman, SR; Huang, KE; Yentzer, B | 1 |
| Ropke, M; Segaert, S | 1 |
| Balkrishnan, R; Feldman, SR; Kakatkar, S; Levi, E; Pathak, P | 1 |
| Chimenti, S; Esposito, M; Frangione, V; Grodzińska, A; Kapińska-Mrowiecka, M; Naldi, L; Ortonne, JP | 1 |
| Badri, T; Daghfous, R; El Aidli, S; Kastalli, S; Lakhoua, G; Mebazaa, A; Sahnoun, R; Zaiem, A | 1 |
| Hol, CW; Lambert, J; Vink, J | 2 |
| Cassano, N; Neri, L; Vena, GA | 1 |
| de Jong, EM; Mul, K; Oostveen, AM; Seyger, MM; van de Kerkhof, PC; van Geel, MJ | 1 |
| Kragballe, K; van de Kerkhof, P | 1 |
| Bewley, A; Cambazard, F; Daudén, E; Girolomoni, G; Lambert, J; Reich, K | 1 |
| Aberer, W; Böckle, BC; Jara, D; Nindl, W; Sepp, NT | 1 |
| Debarre, JM; Gooderham, M; Goodfield, M; Keddy-Grant, J; Kurvits, M; Xu, Z | 1 |
| Ardabili, M; Augustin, M; Bonnekoh, B; Mrowietz, U; Reich, K; Reusch, M; Rosenbach, T; Thaçi, D | 1 |
| Guo, XF; Li, G; Li, XY; Lu, CJ; Ou, AH; Wen, ZH; Xuan, ML; Yan, YH; Yao, DN | 1 |
| Agrawal, S; Harde, H; Jain, S; Katariya, M; Sonawane, R | 1 |
| Clonier, F; Olesen, M; Queille-Roussel, C | 1 |
| Cantrell, W; Elewski, B; Kole, L | 1 |
| Del Rosso, JQ | 1 |
| de Jong, EM; Donders, AR; Oostveen, AM; Seyger, MM; van de Kerkhof, PC | 1 |
| Bachelez, H; de Jong, EM; Gisondi, P; Mrowietz, U; Puig, L; Reich, K; Warren, RB; Zschocke, I | 1 |
| Hendriks, AG; Joosten, I; Keijsers, RR; Koenen, HJ; van de Kerkhof, PC; van Erp, PE | 1 |
| Miracapillo, A; Neri, L | 1 |
| de Jonge, CS; Hendriks, AG; Lucas, M; Seyger, MM; Steenbergen, W; van de Kerkhof, PC | 1 |
| Clark, A; Feldman, SR; Harrison, J; Huang, KE; Sandoval, LF | 1 |
| Bagel, J; Knuckles, ML; Levi, E; Tyring, S | 1 |
| Lacour, JP; Olesen, M; Queille-Roussel, C; Villumsen, J | 1 |
| Cui, P; Facy, P; Gao, T; Ge, M; Gu, J; Hao, F; Kurvits, M; Li, R; Ma, L; Sun, Q; Wang, G; Xu, J; Xu, Z; Yang, H; Yang, Q; Zheng, M | 1 |
| Bang Pedersen, C; Olesen, M; Papp, K; Taraska, V; Tuppal, R | 1 |
| Bagel, J; Bruce, S; Koo, J; Olesen, M; Tyring, S; Villumsen, J; Werschler, WP | 1 |
| Gual, A; Molin, S; Pau-Charles, I | 1 |
| Bagel, J; Leonardi, C; Olesen, M; Pariser, D; Stein Gold, L; Xu, Z; Yamauchi, P; Østerdal, ML | 1 |
| Lovato, P; Norsgaard, H; Røpke, MA; Tokura, Y | 1 |
| Fowler, JF; Hebert, AA; Sugarman, J | 1 |
| Jackson, JM; Knuckles, ML; Stein Gold, L; Weiss, JS | 1 |
| Einecke, D | 1 |
| Deng, JW; Guo, XF; He, ZH; Li, G; Li, XY; Lu, CJ; Ou, AH; Wen, ZH; Xie, XL; Xuan, ML; Yan, YH; Yao, DN | 1 |
| Stein Gold, LF | 1 |
| Feldman, SR; Hill, D; Kin, KC | 1 |
| Ohashi, T; Suzuki, Y; Yamamoto, T | 1 |
| Aoi, N; Harada, Y; Kaneko, S; Morita, E; Murata, S | 1 |
| Chantzaras, A; Kontochristopoulos, G; Kouris, A; Petridis, A; Yfantopoulos, J | 1 |
| Larsen, LS; Lophaven, KW; McHorney, CA; Moeller, AH; Pedersen, CB; Reaney, M | 1 |
| Bang, B; Cambazard, F; Griffiths, CE; Kalb, RE; Lowson, D; Paul, C; Stein Gold, L | 1 |
| Koo, J; Lebwohl, M; Menter, A; Rosen, M; Stein Gold, L; Villumsen, J | 1 |
| Bagel, J; Leonardi, C; Moller, A; Osterdal, ML; Pariser, D; Stein Gold, L; Xu, Z; Yamauchi, P | 1 |
| Frampton, JE; Kim, ES | 1 |
| Li, G; Lu, C; Lu, L; Wen, Z; Xuan, M; Yan, Y; Zhou, L | 1 |
| Choe, YB; Choi, JH; Kim, KJ; Kim, NI; Kim, TY; Lee, JH; Park, CJ; Song, HJ; Youn, JI; Youn, SW | 1 |
| Glumoff, V; Haapasaari, KM; Hägg, PM; Hurskainen, T; Kokkonen, N; Kubin, ME; Palatsi, R; Tasanen, K; Väyrynen, JP | 1 |
| Bang, B; Lebwohl, M; Paul, C | 1 |
| Yamauchi, P | 1 |
| Calzavara Pinton, P; Cicchetti, A; Cristaudo, A; Girolomoni, G | 1 |
| Clonier, F; Lacour, JP; Nørremark, K; Queille-Roussel, C; Rosen, M | 1 |
| Hirano, T; Okubo, Y; Tsuboi, R; Usui, K | 1 |
| Arango-Duque, LC; Fernández López, E; Palacios Álvarez, I; Roncero-Riesco, M; Usero Bárcena, T | 1 |
| Gold, LS; Lebwohl, M; Leonardi, C; Menter, A; Møller, A; Paul, C; Reich, K; Warren, RB | 1 |
| Bissonnette, R; Dickstein, D; Estrada, YD; Guttman-Yassky, E; Labuda, T; Malik, K; Oliva, M; Peng, X; Suarez-Farinas, M; Suprun, M; Todd, D; Ungar, B; Xu, H | 1 |
| Arita, K; Hirai, M; Kurebayashi, Y; Mori, H; Yamaguchi, T | 1 |
| Bachelez, H; de Jong, EMGJ; Gisondi, P; Mrowietz, U; Ortland, C; Puig, L; Reich, K; Warren, RB; Zschocke, I | 1 |
| Austad, J; Berne, B; Burden, AD; de Unamuno, P; Figueiredo, A; Ganslandt, C; Jemec, GB; Ortonne, JP; Poulin, Y | 1 |
| Bourcier, M; Cambazard, F; Clonier, F; Gupta, G; Kidson, P; Larsen, FG; Luger, TA; Shear, NH | 1 |
| Gibney, J; Hughes, R; Kirby, B | 1 |
| Kamino, H; Lane, TK; Meehan, S; Pomeranz, MK; Walters, RF | 1 |
| Anstey, A; Barnes, L; Bolduc, C; Hoffmann, V; Reich, K; Saari, S; Segaert, S; Vaillant, L; van de Kerkhof, PC | 1 |
| Tsiskarashvili, NI; Tsiskarashvili, NV | 1 |
| Bröcker, EB; Garbaraviciene, J; Hamm, H; Seitz, CS | 1 |
| Abeni, D; Alessandroni, L; Di Pietro, C; Didona, B; Gisondi, P; Rota, L; Sampogna, F; Tabolli, S | 1 |
| Abramovits, W; Colón, LE; Gottschalk, RW; Johnson, LA; Menter, A | 1 |
| Avgerinou, G; Belyayeva, H; Daniel Iii, CR; Gregoriou, S; Katsambas, A; Kontochristopoulos, G; Larios, G; Rigopoulos, D; Stamou, C; Verra, P | 1 |
| Hoffmann, V; Kragballe, K; Nordin, P; Ortonne, JP; Segaert, S; Tan, J | 1 |
| Ganslandt, C; Kragballe, K; Nordin, P; Ortonne, JP; Segaert, S; Tan, J | 1 |
| Bordas, X; Borrego, L; Brufau, C; Caballé, G; Carrascosa, JM; Colomé, E; Fernández-López, E; Fuertes, A; Hernanz, JM; Herrera, E; Rodríguez-Fernández-Freire, L; Tuneu, A; Vanaclocha, F; Zulaica, A | 1 |
| Collins, P; Kirby, B; Langan, SM; Tobin, AM | 1 |
| Guenther, LC | 2 |
| Giovannini, A; Girolomoni, G; Gisondi, P; Rosina, P | 1 |
| Chimenti, S; Frascione, P; Gramiccia, T; Saraceno, R | 1 |
| Hagberg, O; Hoffmann, V; Kemp, K; Kvist, PH; Røpke, MA; Svensson, L | 1 |
| de Boer-van Huizen, RT; Otero, ME; Pasch, MC; van de Kerkhof, PC; van der Velden, HM; van Erp, PE; van Lingen, RG | 1 |
| Giannitelli, M; Lahfa, M; Livideanu, C; Maza, A; Meyer, N; Paul, C | 1 |
| Alomar, A; Barco, D; Puig, L; Vilarrasa, E | 1 |
| Arenberger, P; Chimenti, S; Esslinger, HU; Ghislain, PD; Khemis, A; Kragballe, K; Kupper, H; Ortonne, JP; Saurat, JH; Sprøgel, P; Thaçi, D; Unnebrink, K | 1 |
| Belo, L; Castro, E; Coimbra, S; Figueiredo, A; Oliveira, H; Quintanilha, A; Reis, F; Rocha, S; Rocha-Pereira, P; Santos-Silva, A; Teixeira, F | 2 |
| Enevold, A; Ganslandt, C; Jemec, GB; van de Kerkhof, PC | 1 |
| Hino, R; Kabashima, R; Kawakami, C; Nakamura, M; Sugita, K; Tokura, Y | 1 |
| Augustin, M; Herberger, K; Kornek, T; Radtke, MA | 1 |
| Fleming, C; Ganslandt, C; Leese, GP | 1 |
| Kircik, LH; Kumar, S | 1 |
| Cholongitas, E; Ioannidou, D; Kokolakis, GP; Krüger-Krasagakis, S | 1 |
| Appell, M; Bibby, A; Foster, R; Hamilton, T; Lee, M; Mendoza, N; Tyring, S | 1 |
| de Peuter, R; Jansen, JP; Ryttov, J; van de Kerkhof, P | 1 |
| Affleck, AG; Auland, M; Bottomley, JM; Jackson, P; Ryttov, J | 1 |
| Freeman, K | 1 |
| Bottomley, JM; Ryttov, J; Taylor, RS | 1 |
| Chimenti, S; Gniadecki, R; Goldblum, O; Kupper, H; Ortonne, JP; Reich, K; Sprøgel, P; Thaçi, D; Unnebrink, K | 1 |
| Curčić, D; Gupta, A; Langley, RG; Papp, K; Wexler, D; Østerdal, ML | 1 |
| Alex, A; Drexler, W; Heard, CM; Porter, RM; Povazay, B; Thomas, CP; Zulfakar, MH | 1 |
| McCormack, PL | 2 |
| Murphy, G; Reich, K | 1 |
| Eicke, C; Macheleidt, O; Mrowietz, U | 1 |
| Cassano, N; Galluccio, A; Pezza, M; Vena, GA; Vestita, M | 1 |
| Calzavara-Pinton, P; Rossi, MT; Sala, R; Venturini, M | 1 |
| Kircik, LH | 1 |
| Bhutani, T; Busse, KL; Koo, J; Patel, T | 1 |
| Enevold, A; Ganslandt, C; Hoffmann, V; Queille-Roussel, C | 1 |
| Flores, R; Gottlieb, A; Levy, R; Liang, J; Punwani, N; Scherle, P; Shi, J; Williams, W; Yeleswaram, S | 1 |
| Li, W; Man, XY | 1 |
| Muro, M; Natsume, S; Okubo, Y; Tsuboi, R; Usui, K | 1 |
| Fischer, G; Hong, E; Kapila, S | 1 |
| Davis, SA; Feldman, SR; Koo, JY; Wong, JW | 1 |
| Crowe, M; Rallis, E; Verros, C | 1 |
| Caveney, SW; Gottschalk, RW; Menter, MA | 1 |
| Ayala, F; Cannavò, SP; Chimenti, S; De Pità, O; Girolomoni, G; Peserico, A; Vena, GA | 1 |
| Boyce, BM; Bukhalo, M; Ganslandt, C; Gold, LS; Grekin, S; Kempers, S; Lebwohl, M; Menter, A; Villumsen, J | 1 |
| Cai, SQ; Lu, ZF; Luo, D; Wu, XJ; Zheng, M; Zhu, JW | 1 |
| Bibby, AJ; Buckley, C; Decroix, J; Douglas, WS; Gulliver, W; Iglesias, L; Krogstad, AL; Larsen, FG; Mrowietz, U; Ortonne, JP; Poulin, Y | 1 |
| Chu, AC; Garcia-Diez, A; Guenther, L; Kragballe, K; Snellman, E; Springborg, J; Tegner, E; Van de Kerkhof, PC | 1 |
| Poulin, Y | 1 |
| Bibby, AJ; Bissonnette, R; Cambazard, F; Chu, AC; Decroix, J; Douglas, WS; Kaufmann, R; Lowson, D; Mascaro, JM; Murphy, GM; Stymne, B | 1 |
| Caca-Biljanovska, NG; V'lckova-Laskoska, MT | 1 |
| Boyden, B; Burg, G; Chu, A; Guenther, L; Guilhou, JJ; Hanssen, LI; Harvima, RJ; Kaufmann, R; Larsen, FG; Papp, KA; Rogers, S; Talbot, D; Tegner, E; van de Kerkhof, PC | 1 |
| Glander, HJ; Haustein, UF; Paasch, U; Rogalski, C | 1 |
| Camarasa, JM; Dubertret, L; Ortonne, JP | 1 |
| Hughes-Formella, BJ; Traulsen, J | 1 |
| NOHARA, N; TODA, M; TSUKINOKI, K | 1 |
| ATKINSON, RM; MCKENZIE, AW | 1 |
| CHURCH, R; LYELL, A; MCKENNA, WB; MILNE, JA; OVERTON, J; WILKINSON, DS; WILLIAMS, DI | 1 |
| CORDERO, A | 1 |
| EAKINS, TS; HEANY, SH; MITCHELL, DM | 1 |
| BUCKLEY, DB | 1 |
| CRETIN, J; FANTINO, R; MICHEL, PJ | 1 |
| BANERJEE, AK; CHOWDHURY, DS | 1 |
| WEINBERG, M; ZELONY, A | 1 |
| Kostakis, PG; Panagiotopoulos, A; Papakonstantinou, AM; Petridis, AD; Stavropoulos, PG | 1 |
| Lui, H; Shapiro, J | 1 |
| Berends, M; de Jong, EM; Muys, L; van de Kerkhof, PC; van Erp, PE; Vissers, WH | 1 |
| Al-Waili, NS | 1 |
| Garrott, HM; Walland, MJ | 1 |
| Ortonne, JP | 1 |
| Hibon, JF | 1 |
| Cambazard, F | 1 |
| Estebaranz, JL; Fleming, C; Hanssen, LI; Kragballe, K; Lui, H; Noerrelund, KL; Ortonne, JP; Persson, LM; Uurasmaa, T; Wozel, G | 1 |
| Traulsen, J | 1 |
| van de Kerkhof, PC | 2 |
| Goodfield, M; Kaufmann, R; Lecha, M; Ortonne, JP | 1 |
| Flagothier, C; Piérard, GE; Piérard-Franchimont, C; Uhoda, I | 1 |
| Fenton, C; Plosker, GL | 1 |
| Cambazard, F; Kragballe, K; Murray, S; van de Kerkhof, PC; Wasel, N | 1 |
| Guignard, E; Ortonne, JP; Peeters, P; Sitbon, R | 1 |
| Martinez, I; Romero, P; Salvat, M | 1 |
| Delvoye, P; Flagothier, C; Henry, F; Piérard, GE; Piérard-Franchimont, C | 1 |
| Chrysomallis, F; Kastanis, A; Lazaridou, E; Loannides, D; Vakirlis, E | 1 |
| Kragballe, K; van de Kerkhof, PC | 1 |
| Alhaddar, J; Duweb, G; Eljehawi, N; Elsherif, B; Makhlouf, H | 1 |
| Charakida, A; Charakida, M; Chu, AC; Dadzie, O; Evangelou, G; Teixeira, F | 1 |
| Downs, AM | 1 |
| de Fontaine, S; de Lathouwer, OG | 1 |
| Flagothier, C; Henry, F; Piérard, GE; Piérard-Franchimont, C | 1 |
| Austad, J; Barnes, L; Bibby, A; Cambazard, F; de la Brassinne, M; Fleming, C; Heikkilä, H; Jolliffe, D; Kragballe, K; Peyri, J; Svensson, A; Toole, J; Wozel, G | 1 |
| Bovenschen, HJ; de Jong, EM; Gerritsen, WJ; van de Kerkhof, PC | 1 |
| Bibby, A; Cambazard, F; Foster, R; Haverkamp, C; Martinez Escribano, JA; Naeyaert, JM; Thaçi, D; Vender, R; White, S | 1 |
| Bovenschen, HJ; Erceg, A; Seyger, MM; van de Kerkhof, PC | 1 |
| Adriaans, B; Fergusson-Wood, LA; Griffiths, MR; Porter, W | 1 |
| Anstey, AV; Kragballe, K | 1 |
| Roebuck, HL | 1 |
| Altmeyer, P; Bräutigam, M; Brockmeyer, NH; Gambichler, T; Hyun, J; Kreuter, A; Sommer, A | 1 |
| Austad, J; Barnes, L; Bibby, A; Cambazard, F; de la Brassinne, M; Fleming, C; Heikkilä, H; Kragballe, K; Peyri Rey, J; Svensson, A; Toole, J; Williams, Z; Wozel, G | 1 |
| Bovenschen, HJ; de Jong, EM; Gerritsen, WJ; Seyger, MM; van de Kerkhof, PC; van Rens, DW | 1 |
| Bellino, M; Cassano, N; Coviello, C; Loconsole, F; Miracapillo, A; Vena, GA | 1 |
| Cassano, N; Vena, GA | 1 |
| Kragballe, K; Mrowietz, U; Segaert, S; van de Kerkhof, PC | 1 |
| Bovenschen, HJ; Erceg, A; Seyger, MM; Van De Kerkhof, PC; Van Vlijmen-Willems, I | 1 |
| Lebwohl, MG | 1 |
| Toole, JW | 1 |
| Auland, ME; Bottomley, JM; Boyd, G; Douglas, WS; Morais, J | 1 |
| Arai, K; Hirano, T; Oka, K; Okubo, Y; Tsuboi, R; Uchiyama, T | 1 |
| Augustin, M; Lapp, C; Moehling, U; Peeters, P; Radtke, M | 1 |
| Chrysomallis, F; Papagaryfallou, I; Patsatsi, A; Sotiriadis, D; Sotiriou, E | 1 |
| Gupta, R; Gupta, S | 1 |
| Andreassi, L; Ayala, F; Bongiorno, MR; Chimenti, S; Giannetti, A; Lisi, P; Martini, P; Peris, K; Peserico, A; Saraceno, R | 1 |
| Andreoli, GM; Calvieri, S; Cantisani, C; Cantisani, V; Cigna, E; Miller, DM; Scuderi, N; Solivetti, F | 1 |
| Fernandes, M; Rao, GN; Vemuganti, GK | 1 |
| Buckley, C; Cambazard, F; Hoffmann, V; Milsgaard, M; Saari, S; Shapiro, J | 1 |
| Chen, CY; Chen, YH; Lo, PY; Tzung, TY; Yang, CY | 1 |
| Zimmerman, EH | 1 |
| Munro, DD; Rhodes, EL; Wilson, HT | 1 |
| Freshwater, DG | 1 |
| de Jonge, H; Polano, MK; Pot, F; vd Harst, LC | 1 |
| Adams, LW; Oakley, CA; Prescott, RJ; Priestley, GC | 1 |
| Larkö, O; Svartholm, H; Swanbeck, G | 1 |
| Lassus, A; Salde, L | 1 |
| Hagemeier, HH; Nolting, S | 1 |
| de la Brassine, M; Kint, A; Lachapelle, JM; Tennstedt, D | 1 |
| Fabry, H; Yawalkar, SJ | 1 |
| Bonfacini, V; Candiani, F; Galbiati, G | 1 |
| Weitgasser, H; Yawalkar, SJ | 1 |
| Renovanz, HD; Rozman, TA; Wiedey, KD | 1 |
| Aso, M | 1 |
| Bakkers, EJ; Go, MJ; Montnor, LP; Roessel, FE; van der Wateren, AR; van Dijk, E; Wuite, J | 1 |
| Gip, L; Hamfelt, A | 2 |
| Blum, G; Kröpfli, P; Küng, D; Suter, H | 1 |
| Krebs, A; Roduner, J | 1 |
| Bigliardi, P | 1 |
| Ashton, RE; Koudsi, H; Lowe, NJ; Schaefer, H; Verschoore, M | 1 |
| Fleuren, E; Mier, PD; van de Kerkhof, PC; van Rennes, H | 1 |
| Blyth, B; Hindson, C; Spiro, J | 1 |
| Lodolo, JC | 1 |
| Cabrera, ME | 1 |
| Hillström, L | 1 |
| Fredriksson, T; Salde, L | 1 |
| Frederiksen, B; Larsson, L; Svartholm, H | 1 |
| Christiansen, JV; Holm, P; Møller, R; Reymann, F; Schmidt, H | 1 |
| Castiglioni, G; Tomasini, C | 1 |
| Malfitan, VA | 1 |
| Danie, MJ; Du Vivier, A; Eilon, L; Hehir, M; Shenoy, EV | 1 |
| Durocher, LP; Elie, R; Kavalec, EC | 1 |
| Lane, AT; Wachs, GN; Weston, WL | 1 |
| Leer, JA | 2 |
| Allenby, CF; Sparkes, CG | 1 |
| Hjorth, N; Salde, L; Schmidt, H | 1 |
| Beck, M; Berger, C; Filipp, N; Hundertmark, U; Loewel, R | 1 |
| Høvding, G | 1 |
| Leibsohn, E | 1 |
| Aggerwal, A; Maddin, S | 1 |
| Hillström, L; Pettersson, L; Svensson, L | 1 |
| Guilhou, JJ; Guillot, B; Meynadier, J; Peyron, JL | 1 |
| Cornell, RC; Stoughton, RB | 1 |
| Gutierrez Aldana, G | 1 |
| Confalonieri, F; Parisio, E; Pedretti, D | 1 |
| Ameglio, F; Bonifati, C; Fazio, M; Pietravalle, M | 1 |
| Ameglio, F; Bonifati, C; Fazio, M; Pietravalle, M; Solmone, M; Trento, E | 1 |
| Kamel, D; Lehto, VP; Oikarinen, A; Pääkkö, P; Soini, Y; Vähäkangas, KV | 1 |
| Arbiser, JL; Arndt, KA; Grossman, K; Kaye, E | 1 |
| Scarpa, C | 1 |
| Aeling, JL; Huff, L; Walsh, P; Weston, WL | 1 |
| Jondreau, L; Kenny, C; Shupack, JL; Stiller, MJ | 1 |
| Beetz, A; Kemény, L; Michel, G; Nowok, K; Ried, C; Ruzicka, T | 1 |
| Gopal, J; Mishra, RN; Pandey, SS; Singh, S | 1 |
| Dezerega, V; Franchi, P; Perucca, E; Rodríguez, A; Ruiz, J | 1 |
| Roberts, DT | 1 |
| Finkel, LJ; Griffiths, CE; Hamilton, TA; McMichael, AJ; Rafal, ES; Talwar, HS; Voorhees, JJ | 1 |
| Singh, S | 1 |
| Crosti, C; Finzi, AF; Mian, E; Scarpa, C | 1 |
| Amano, T; Nakayama, Y; Seki, K | 1 |
| Dromgoole, SH; Killey, FP; Krueger, GG; O'Reilly, MA; Weidner, M | 1 |
| Gilbertson, EO; Mulford, MI; Piacquadio, DJ; Spellman, MC | 1 |
| Barnes, L; Hamberg, KJ; Hutchinson, P; Kragballe, K; Murphy, F; Møller, S; Ruzicka, T; Van De Kerkhof, PC | 1 |
| Benelli, C; Cameli, N; Cannata, GE; Kokely, F; Piraccini, BM; Plozzer, C; Tosti, A | 1 |
| Krivosheev, BN | 1 |
| Erkko, P; Granlund, H; Lauerma, AI; Reitamo, S; Remitz, A | 1 |
| Guzzo, C; Margolis, D; Miller, JJ; Roling, D | 1 |
| Agius, A; Borg, E; Pace, JL | 1 |
| Hecker, D; Lebwohl, M; Worsley, J; Yueh, G | 1 |
| Pandey, SS; Reddy, DC; Singh, S | 1 |
| Braun, R; Dotterud, LK | 1 |
| Brice, DM; Danesh-Meyer, MJ | 1 |
| van de Kerkhof, PC; van Erp, PE; van Rossum, MM | 1 |
| Barbaud, A; Gillet, P; Reichert-Pénétrat, S; Schmutz, JL; Tréchot, P | 1 |
| Handler, RH; Medansky, RS | 1 |
| Hradil, E; Lindström, C; Möller, H | 1 |
| Gip, LJ; Nilsson, JE | 1 |
| Burton, JL; Cunliffe, WJ; Holti, G; Wright, V | 1 |
| Fredriksson, T; Gip, L; Hamfelt, A | 1 |
| Hellgren, L | 1 |
| Rees, RB | 1 |
| Parish, LC; Witkowski, JA | 1 |
| Tollofsrud, A | 1 |
| Cotton, DW; van Rossum, E | 1 |
| Kehlet, H; Reymann, F | 1 |
| Sparkes, CG; Stevanovic, DV; Wilson, L | 1 |
| Frost, P; Gomez, EC; Kaminester, L | 1 |
| Tazelaar, DJ | 1 |
| Lassus, A | 3 |
| Gould, PW; Wilson, L | 1 |
| Burger, PM; Polano, MK; Smeenk, G; van der Harst, LC; van der Rhee, HJ | 1 |
| Anderson, TF; Duell, EA; Hamberg, M; Hammarström, S; Stawiski, MA; Voorhees, JJ | 2 |
| Mugglestone, CJ; Wendt, H; Wiseman, RA | 1 |
| Keczkes, K; Mugglestone, CJ; Teasdale, P; Wiseman, RA | 1 |
| Lewis, MB | 1 |
| Sparkes, CG; Vollum, DI | 1 |
| Afzelius, HW; Jacobsen, KU | 1 |
| Esser, B | 1 |
| Shimao, S | 1 |
| Baabour, SD; Magnin, PH; Torchinsky, O | 1 |
| Sparkes, CG; Woodbridge, PA | 1 |
| Almeyda, J; Wood, H | 1 |
| Hanke, CW; Roenigk, HH; Steck, WD | 1 |
| Halsos, AM | 1 |
| Carruthers, JA | 1 |
| Adam, BA | 1 |
| Wilson, L | 2 |
| Corbett, MF | 1 |
| Charney, P | 1 |
| Björnberg, A; Hellgren, L | 2 |
| Kukita, A; Miyachi, Y; Mizuchi, A; Tamaki, K | 1 |
| Ronn, HH | 1 |
| Vanderploeg, DE | 1 |
| Barsky, S | 1 |
| Seville, RH | 1 |
| Mali, JW | 1 |
| Bluefarb, SM; Howard, FM; Leibsohn, E; Schlagel, CA; Wexler, L | 1 |
| Hersle, K; Mobacken, H | 1 |
| August, PJ; Carruthers, JA; Staughton, RC | 1 |
| Clayton, R; du Vivier, AW; France, DM; Munro, DD; Robinson, TW; Sparkes, CG | 1 |
| Barnetson, RS; Hardie, RA; Waring, AJ | 1 |
| Konrad, K | 1 |
| Kaidbey, KH | 1 |
| Charney, P; Superfon, N | 1 |
| Garretts, M | 1 |
| Nair, BK; Nair, CH | 1 |
| Clark, RF; Clement, ER | 1 |
| Bleeker, J | 1 |
| Savin, RC | 1 |
| August, PJ; Staughton, RC | 1 |
| Boxley, JD; Dawber, RP; Summerly, R | 1 |
| Benazéraf, C; Bourgeois-Spinasse, J; Cardinne, A; Durepaire, R; Edelson, Y; Futchbaum, G; Girard, J; Grupper, C; Rousselet, G | 1 |
| Munro, DD; Wilson, L | 1 |
| Floden, CH; Kurwa, AR; Samman, P; Woodbridge, P | 1 |
| Weitgasser, H | 1 |
| Meyer-Rohn, J | 1 |
| Marriott, PJ; Munro, DD | 1 |
| Goodwin, P | 1 |
| Fedi, AM; Leoncini, P; Lotti, T; Meo, AL; Rizzo, A | 1 |
| Berth-Jones, J; Fletcher, A; Hutchinson, PE | 1 |
| Clissold, SP; Murdoch, D | 1 |
| Freije, L; Leffell, DJ; Leneveu, MC; Watsky, KL; Wenck, HA | 1 |
| Ogawa, H; Yamada, H | 1 |
| Long, CC; Marks, R | 1 |
| de Jong, EG; de Mare, S; van de Kerkhof, PC | 1 |
| Basta-Juzbasić, A; Dobrić, I; Mustac-Gotovac, M; Paljan, D; Pasić, A | 1 |
| Korsukewitz, G; Mensing, H; Yawalkar, S | 1 |
| Finlay, AY; Long, CC | 1 |
| Jones, ML; Katz, HI; Krueger, GG; Medansky, RS; Mooney, JJ; Prawer, SE; Samson, CR | 1 |
| Colver, GB; Duff, GW; Kemmett, D; Symons, JA | 1 |
| Braun-Falco, O; Korting, HC; Schäfer-Korting, M; Zienicke, H | 1 |
| Kaukhova, OIa; Kubanov, AA; Shakhtmeĭster, IIa; Skripkin, IuK | 1 |
| Mahrle, G; Schulze, HJ | 1 |
| Ohayon, M; Wilkinson, RD | 1 |
| Ellis, CN; Goldfarb, MT; Gupta, AK; Hamilton, TA; Voorhees, JJ | 1 |
| Arnold, WP; Mier, PD; van de Kerkhof, PC; van Hooijdonk, CA | 1 |
| Jegasothy, BV | 1 |
| Freer, JP; Kalb, RE; Krochmal, L; Siskin, SB; Watson, WA | 1 |
| Jaeger, L | 1 |
| Chuang, TY; Samson, CR | 1 |
| Katz, HI; Mooney, JJ; Prawer, SE; Samson, CR | 1 |
| Bunker, CB; Dowd, PM; English, JS; Greaves, MW; Ruthven, K | 1 |
| Broby-Johansen, U; Kristensen, JK | 1 |
| Möller, H | 1 |
| Fairris, GM; Leatherdale, BA; Tymms, DJ; White, JE | 1 |
| Nolting, S | 1 |
| Tanaka, K | 1 |
| Barr, RM; Cunningham, FM; Greaves, MW; Mallet, AI; Mistry, K; Wong, E; Woollard, PM | 1 |
| Baba, S; Suzuki, H; Usuba, S | 1 |
| Goh, CL | 1 |
| Johannesson, A; Lindelöf, B | 2 |
| Harris, DW; Hunter, JA | 1 |
| Damasio, M; Tacchini, GA | 1 |
| Ashworth, J; Booker, J; Breathnach, SM | 1 |
| Griffin, TD; Lattanand, A; VanScott, EJ | 1 |
| Moncada, B; Sandoval Cruz, M | 1 |
| Clement, MI; du Vivier, A; Hehir, ME; Monk, BE; Pembroke, AC | 1 |
| Baker, BS; Fry, L; Griffiths, CE; Powles, AV; Valdimarsson, H | 1 |
| Anand, S; Arora, PN; Chattopadhyay, SP; Sharma, SD | 1 |
| Cornell, RC; Jacobson, C; Savin, RC | 1 |
| Ellis, CN; Van Scott, EJ | 1 |
| Cornell, RC; Olsen, EA | 1 |
| Hien, NT; Katz, HI; Mastbaum, LI; Mooney, JJ; Prawer, SE; Samson, CR | 1 |
| Dawber, RP; Telfer, NR | 1 |
| van der Velde, EA; Young, E | 1 |
| McKenna, TJ; Meenan, FO; Ohman, EM; Rogers, S | 1 |
| Grivna, EM; Hien, NT; Katz, HI; Prawer, SE; Scott, JC | 1 |
| Hammar, H; Johannesson, A; Lidbrink, P | 1 |
| Feurman, EJ; Yawalkar, SJ | 1 |
| Woodford, R | 1 |
| Christiansen, JV; Foged, E; Holm, P; Jørgensen, AS; Reymann, F | 1 |
| Huntley, AC; Isseroff, R | 1 |
| Cole, G; Jacobson, C; Jegasothy, B; Levine, N; Millikan, L; Olsen, E; Pinnell, S; Porter, M; Weinstein, G | 1 |
| Hogan, DJ; Lane, PR; Sibley, JT | 1 |
| Rozman, TA | 1 |
| Hood, AF; Katz, R | 1 |
| Karlsmark, T; Verdich, J | 1 |
| Richards, RN | 1 |
| Mörtenhumer, M; Oikarinen, A | 1 |
| Bookbinder, SA; Fenske, NA; Spencer, SA; Vasey, FB | 1 |
| Swanbeck, G | 1 |
| Thune, P | 3 |
| Dumas, KJ; Scholtz, JR | 1 |
| Tring, FC | 1 |
| Handler, RM; Medansky, RS | 1 |
| Groth, O; Juhlin, L; Michaëlsson, G; Ohman, S | 1 |
| Cooke, JN; Crow, KD | 1 |
| Nordwall, C | 1 |
| Livingood, CS; Mellinger, RC; Mikhail, GR; Paige, TN; Salyer, HL | 1 |
| Bruni, L; Cerimele, D | 1 |
| Milne, JA | 1 |
| Kalamkarian, AA; Makovoz, VI; Samsonov, VA | 1 |
| O'Loughlin, M | 1 |
| Binder, R; McCleary, J | 1 |
| Meenan, FO | 1 |
| Harris, JJ | 1 |
| Cullen, SI | 1 |
| Woodbridge, P | 1 |
| Baker, H; Ryan, TJ | 1 |
| Munro, DD | 1 |
| Snedden, IB | 1 |
| Foelsche, W | 1 |
| Raab, W; Siber, H | 1 |
| Tan, RS | 1 |
| Fry, L; James, VH; Walker, SR; Wilson, L | 1 |
| Rostenberg, A; Vogt, FC | 1 |
| Portnoy, B; Sarkany, I | 1 |
| Fry, L; Macdonald, A | 2 |
| Harman, RR; Jensen, NE; MacConnell, LE; Mathews, CN | 1 |
| Hall-Smith, P | 1 |
| Guss, SB; Key, DJ; Peck, GL | 1 |
| Bartruff, JK; Gregory, JF; Smith, EB | 1 |
| Neering, H; Roeleveld, CG; van der Kroon, HV | 1 |
| Alexander, S; Lyne, C | 1 |
| Garrett, RT; Marks, JH | 1 |
| Feuerman, E | 2 |
| Stankier, L | 1 |
| Sparkes, CG; Wilson, L | 1 |
| Bagatell, FK; Leibsohn, E | 1 |
| Fry, L; Goodwin, PG; Hamilton, S | 1 |
| Ross, CM | 1 |
| McCuistion, CH; Schoch, EP; Warthan, TL | 1 |
| Becke, RF | 1 |
| Hendrikse, JC; Moolenaar, AJ | 1 |
| Runikis, JO; Stewart, WD; Verma, SC; Wallace, S | 1 |
| Clift, DC; Munro, DD | 1 |
| Fredriksson, T | 1 |
| Durham, GA; Morgan, JK | 1 |
| Ashurst, PJ; Caldwell, IW; Champion, RH; Hall-Smith, SP; Milne, JA | 1 |
| Carbone, G; Massone, L | 1 |
| Sarkany, I | 1 |
| Bywaters, EG; Dixon, AS | 1 |
| Zelikov, AKh | 1 |
| Gebhardt, R; Holzmann, H; Morsches, B | 1 |
| Goodwin, M; Kelly, A; McCluggage, J; Nelson, K | 1 |
| Hannuksela, M; Uitto, J | 1 |
| Portnoy, B | 1 |
| Pfister, R | 1 |
| Barrett, CW; Caron, GA; Hadgraft, JW; Sarkany, I | 1 |
| Piana, T | 1 |
| Stahle, IO; Webb, JG | 1 |
| Warner, J; Williams, DI; Wilson, LC | 1 |
| Thomsen, K | 1 |
| Stahle, IO | 1 |
| Stankler, L | 1 |
| Mikhail, GR | 1 |
| Kawamura, Y; Morito, S; Shimizu, M | 1 |
| Barrière, H; Bureau, B; Bureau, Y; Litoux, P | 1 |
| Fine, S; Hewitt, R; Hodge, DI; Lustman, F; Simpson, EA | 1 |
| Donald, GF; Hunter, GA | 1 |
| Meynadier, J; Rimbaud, P | 1 |
| Felzmann, B | 1 |
| Magaña Lozano, M | 1 |
| Cordero, AA | 1 |
| Luscombe, HA | 1 |
| Butler, J | 1 |
| Salfeld, K | 1 |
| Kotnik-Zdraveva, G; Schnyder, UW | 1 |
57 review(s) available for betamethasone and Psoriasis
| Article | Year |
|---|---|
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis.
Topics: Betamethasone; Calcitriol; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2022 |
Data Mining and Meta-Analysis of Psoriasis Based on Association Rules.
Topics: Betamethasone; Data Mining; Humans; Immunoglobulin A; Psoriasis; Treatment Outcome | 2022 |
Proactive therapy: New perspectives for long-term topical treatment of psoriasis.
Topics: Administration, Topical; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2022 |
Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of Psoriasis.
Topics: Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2023 |
Treatment of Scalp Psoriasis.
Topics: Administration, Topical; Betamethasone; Dermatologic Agents; Humans; Keratolytic Agents; Psoriasis; Scalp; Scalp Dermatoses; Treatment Outcome | 2022 |
Engaging psoriasis patients in adherence and outcomes to topical treatments: A summary from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30
Topics: Administration, Topical; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Motivation; Psoriasis; Treatment Outcome | 2023 |
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30
Topics: Administration, Topical; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Motivation; Psoriasis; Quality of Life; Treatment Outcome | 2023 |
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30
Topics: Adult; Betamethasone; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Combinations; Emollients; Humans; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Venereology | 2023 |
The role of the foam formulation in improving psoriasis treatment acceptability: a real-life experience and a literature review.
Topics: Administration, Topical; Adult; Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Multicenter Studies as Topic; Psoriasis; Treatment Outcome | 2023 |
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE).
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2021 |
Management of Residual Psoriasis in Patients on Biologic Treatment
Topics: Antibodies, Monoclonal, Humanized; Betamethasone; Biological Products; Dermatologic Agents; Drug Combinations; Humans; Infliximab; Psoriasis; Severity of Illness Index | 2020 |
Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Humans; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience.
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Congresses as Topic; Dosage Forms; Drug Combinations; Humans; Medication Adherence; Psoriasis | 2020 |
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis | 2020 |
Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication.
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Biological Products; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Humans; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Thalidomide; Treatment Outcome | 2020 |
Systematic literature review of long-term efficacy data for topical psoriasis treatments.
Topics: Administration, Topical; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2022 |
Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long-term therapy for mild-to-moderate plaque psoriasis.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2021 |
Clinical efficacy and safety of using calcipotriol-betamethasone compounding agent for psoriasis treatment: a systematic review and meta-analysis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2022 |
Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life | 2017 |
How to improve adherence to treatment in patients with mild-to-moderate psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Medication Adherence; Patient Satisfaction; Physician-Patient Relations; Psoriasis; Severity of Illness Index | 2018 |
Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam.
Topics: Administration, Topical; Aerosols; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Psoriasis | 2019 |
The Evolution of Topical Formulations in Psoriasis.
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Randomized Controlled Trials as Topic | 2018 |
Calcipotriene plus betamethasone dipropionate in aerosol foam formulation: will this effective treatment for mild-to-moderate psoriasis change clinical practice?
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Biological Availability; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Italy; Psoriasis; Skin Absorption; Treatment Outcome | 2018 |
Psoriasis-associated itch: etiology, assessment, impact, and management.
Topics: Betamethasone; Calcitriol; Cost of Illness; Dermatologic Agents; Humans; Pruritus; Psoriasis; Quality of Life; Severity of Illness Index | 2020 |
Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Gels; Humans; Medication Adherence; Ointments; Psoriasis | 2014 |
Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
Topics: Administration, Cutaneous; Anthralin; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Nicotinic Acids; Patient Compliance; Pharmaceutical Vehicles; Practice Guidelines as Topic; Psoriasis; Quality of Life; Severity of Illness Index; Tacrolimus; Treatment Outcome; Vitamin D | 2016 |
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2016 |
Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Quality of Life | 2016 |
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Ointments; Psoriasis; Quality of Life; Treatment Outcome | 2017 |
DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Clinical Trials, Phase III as Topic; Humans; Patient Compliance; Psoriasis; Skin Cream; Treatment Outcome | 2017 |
Back to the future: a new topical approach for mild-to-moderate psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Phototherapy; Psoriasis; Severity of Illness Index; Skin Absorption; Treatment Outcome | 2018 |
Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
Topics: Betamethasone; Calcitriol; Cell Differentiation; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Keratinocytes; Psoriasis; Treatment Outcome | 2009 |
Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
Topics: Acitretin; Acrodermatitis; Adalimumab; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Clobetasol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Mycophenolic Acid; Nails; Paronychia; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor Inhibitors | 2010 |
[Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Gels; Humans; Incidence; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2010 |
Scalp psoriasis.
Topics: Betamethasone; Calcitriol; Clobetasol; Coal Tar; Drug Combinations; Glucocorticoids; Humans; Keratolytic Agents; Psoriasis; Scalp Dermatoses | 2010 |
Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris.
Topics: Administration, Topical; Adult; Algorithms; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome | 2011 |
Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Cost-Benefit Analysis; Drug Combinations; Gels; Humans; Models, Econometric; Psoriasis; Scalp Dermatoses; Scotland; Severity of Illness Index; Treatment Outcome | 2011 |
The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence.
Topics: Administration, Topical; Algorithms; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Evidence-Based Practice; Gels; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2011 |
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
Topics: Back; Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Extremities; Gels; Humans; Ointments; Psoriasis; Scalp; Thorax; Treatment Outcome | 2011 |
In touch with psoriasis: topical treatments and current guidelines.
Topics: Administration, Topical; Betamethasone; Calcitriol; Dermatologic Agents; Humans; Practice Guidelines as Topic; Psoriasis | 2011 |
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Extremities; Gels; Humans; Ointments; Psoriasis; Scalp; Torso | 2011 |
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Clobetasol; Drug Combinations; Glucocorticoids; Humans; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Scalp; Severity of Illness Index; Treatment Outcome | 2012 |
Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Glucocorticoids; Humans; Ointments; Psoriasis | 2002 |
Fixed-dose combination therapy for psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Therapy, Combination; Humans; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index | 2004 |
[Clinical experience with Daivobet].
Topics: Betamethasone; Calcitriol; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Humans; Psoriasis; Severity of Illness Index; Treatment Outcome | 2004 |
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
[The calcipotriol-betamethasone dipropionate association].
Topics: Administration, Topical; Betamethasone; Calcitriol; Drug Therapy, Combination; Humans; Inflammation; Psoriasis | 2005 |
Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cell Differentiation; Cell Proliferation; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Synergism; Humans; Keratinocytes; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
[How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Psoriasis | 2006 |
Newer treatment options for patients with moderate-to-severe psoriatic disease.
Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Attitude to Health; Betamethasone; Body Image; Calcitriol; Clobetasol; Dermatologic Agents; Diagnosis, Differential; Drug Monitoring; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Severity of Illness Index | 2006 |
Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
Topics: Administration, Topical; Adrenal Glands; Adult; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clobetasol; Depression, Chemical; Female; Glucocorticoids; Humans; Male; Ointments; Psoriasis; Self Medication | 1998 |
Current dermatologic therapy.
Topics: Acne Vulgaris; Administration, Topical; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Betamethasone; Cryosurgery; Dermatomycoses; Flucytosine; Fluocinonide; Fluorouracil; Herpes Simplex; Humans; Keratosis; Levamisole; Propylene Glycols; Psoriasis; Pyoderma; Skin Diseases; Skin Neoplasms; Vitamin A; Warts | 1976 |
Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris.
Topics: Anthralin; Betamethasone; Calcitriol; Calcium; Cell Differentiation; Cell Division; Combined Modality Therapy; Humans; Psoriasis; Randomized Controlled Trials as Topic | 1992 |
Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
Topics: Administration, Topical; Betamethasone; Clobetasol; Combined Modality Therapy; Drug Administration Schedule; Eczema; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis | 1986 |
Diseases of the skin. Psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthracenes; Anti-Infective Agents, Local; Antineoplastic Agents; Betamethasone; Humans; Hydrocortisone; Methods; Psoriasis; Tars; Triamcinolone Acetonide; Ultraviolet Therapy | 1974 |
289 trial(s) available for betamethasone and Psoriasis
| Article | Year |
|---|---|
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.
Topics: Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life; Treatment Outcome | 2022 |
Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Patient Reported Outcome Measures; Psoriasis; Quality of Life; Treatment Outcome | 2022 |
Impact of fixed-dose combination Cal/BD foam on the work productivity of patients with psoriasis: results from the 52-week randomized, double-blind, PSO-LONG trial.
Topics: Aerosols; Betamethasone; Dermatologic Agents; Double-Blind Method; Drug Combinations; Humans; Psoriasis; Surveys and Questionnaires; Treatment Outcome | 2022 |
Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis.
Topics: Betamethasone; Calcitriol; Emollients; Humans; Inflammation; Interleukin-17; Ointments; Psoriasis | 2022 |
Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease-A hybrid trial using a smartphone application, optical coherence tomography, and patient-reported outcome measures.
Topics: Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Lasers; Mobile Applications; Nail Diseases; Patient Reported Outcome Measures; Psoriasis; Smartphone; Tomography, Optical Coherence; Treatment Outcome | 2022 |
Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color.
Topics: Adult; Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Excipients; Humans; Psoriasis; Skin; Skin Pigmentation; Treatment Outcome | 2023 |
Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.
Topics: Adult; Betamethasone; Dermatologic Agents; Drug Combinations; Emollients; Excipients; Humans; Psoriasis; Skin Pigmentation; Treatment Outcome | 2023 |
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Emollients; Humans; Psoriasis; Treatment Outcome | 2023 |
Efficacy of Calcipotriol-Betamethasone Ointment in Patients with Mild to Moderate Plaque Psoriasis: Subgroup Analyses.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Body Mass Index; Body Weight; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Obesity; Ointments; Psoriasis; Severity of Illness Index | 2019 |
Safety and efficacy of topical, fixed-dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial.
Topics: Adolescent; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Scalp; Treatment Outcome | 2020 |
Safety and efficacy of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to <17 years) with plaque psoriasis: results of a phase II, open-label trial.
Topics: Adolescent; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2020 |
Topical rapamycin versus betamethasone dipropionate ointment for treating oral erosive lichen planus: a randomized, double-blind, controlled study.
Topics: Administration, Topical; Betamethasone; Double-Blind Method; Humans; Lichen Planus, Oral; Neoplasm Recurrence, Local; Ointments; Psoriasis; Sirolimus; Treatment Outcome | 2020 |
Effect of Calcipotriene/Betamethasone Dipropionate 0.005%/0.064% Foam on Target Lesions in Plaque Psoriasis:\
A Post-Hoc Analysis
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Young Adult | 2020 |
Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial.
Topics: Betamethasone; Clobetasol; Dermatologic Agents; Double-Blind Method; Humans; Neoplasm Recurrence, Local; Nicotinic Acids; Psoriasis; Severity of Illness Index; Skin Cream; Treatment Outcome | 2020 |
Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized cl
Topics: Adult; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Humans; Male; Prospective Studies; Psoriasis; Treatment Outcome | 2021 |
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Body Surface Area; Calcitriol; Data Interpretation, Statistical; Dermatologic Agents; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome | 2020 |
Treating Scalp Psoriasis with Calcipotriene/Betamethasone Dipropionate Fixed-dose Combination Cutaneous Foam: Review of Phase 2 Data
Topics: Administration, Topical; Adolescent; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2020 |
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult | 2021 |
Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pruritus; Psoriasis; Quality of Life; Severity of Illness Index; Thalidomide; Treatment Outcome; Visual Analog Scale | 2020 |
Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled
Topics: Adult; Aged; Anti-Inflammatory Agents; Asian People; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Scalp Dermatoses; Solutions; Treatment Outcome | 2020 |
Apremilast with Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis.
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Diarrhea; Drug Combinations; Drug Therapy, Combination; Female; Headache; Humans; Male; Middle Aged; Nausea; Pilot Projects; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome; Young Adult | 2020 |
Pulse-Dye Laser Followed by Betamethasone-Calcipotriol and Fractional Ablative CO2-Laser-Assisted Delivery for Nail Psoriasis.
Topics: Administration, Topical; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Humans; Lasers, Dye; Male; Middle Aged; Nail Diseases; Prospective Studies; Psoriasis; Young Adult | 2021 |
A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Skin Cream; Treatment Outcome | 2021 |
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase).
Topics: Administration, Cutaneous; Adult; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2021 |
The Effect on BSA of Proactive Management versus Reactive Management of Psoriasis With Fixed-Dose Cal/BD Foam in the PSO-LONG Study.
Topics: Aerosols; Betamethasone; Body Surface Area; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Humans; Maintenance Chemotherapy; Psoriasis; Quality of Life; Recurrence; Remission Induction; Secondary Prevention; Severity of Illness Index; Treatment Outcome | 2021 |
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland.
Topics: Aerosols; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Finland; Humans; Psoriasis; Recurrence; Treatment Outcome | 2022 |
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Recurrence; Treatment Outcome | 2022 |
Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Cross-Over Studies; Female; Humans; Male; Middle Aged; Patient Compliance; Patient Preference; Prospective Studies; Psoriasis; Severity of Illness Index; Surveys and Questionnaires; Young Adult | 2017 |
A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Severity of Illness Index; Skin; Treatment Outcome; Water Loss, Insensible | 2017 |
Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial.
Topics: Administration, Topical; Betamethasone; Calcitriol; Dermatologic Agents; Humans; Medication Adherence; Mobile Applications; Psoriasis; Single-Blind Method | 2018 |
A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Mobile Applications; Psoriasis; Reminder Systems; Severity of Illness Index; Smartphone; Time Factors; Treatment Outcome; Young Adult | 2018 |
Therapeutic equivalence of two formulations of calcipotriol-betamethasone ointment: a multicentre, randomized, double-blind study in adult patients with chronic plaque psoriasis.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Double-Blind Method; Drug Combinations; Drugs, Generic; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Treatment Outcome | 2018 |
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
Topics: Absenteeism; Aerosols; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Gels; Humans; Medication Adherence; Middle Aged; Pruritus; Psoriasis; Quality of Life; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome | 2018 |
Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Recurrence; Treatment Outcome; Ultrasonography; Ultraviolet Therapy; Young Adult | 2019 |
A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Biological Therapy; Calcitriol; Dermatologic Agents; Drug Compounding; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 2018 |
Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Clobetasol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Female; Humans; Keratolytic Agents; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Single-Blind Method; Tretinoin; Young Adult | 2018 |
The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees
Topics: Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Elbow Joint; Female; Humans; Knee Joint; Male; Middle Aged; Pilot Projects; Psoriasis; Severity of Illness Index; Treatment Outcome | 2019 |
Auricular acupressure as a complementary therapy for psoriasis vulgaris: study protocol for a multicenter randomized controlled trial.
Topics: Acupressure; Adolescent; Adult; Aged; Betamethasone; Calcitriol; Ear; Humans; Middle Aged; Ointments; Outcome Assessment, Health Care; Psoriasis; Randomized Controlled Trials as Topic; Young Adult | 2019 |
Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet® Gel) and improvement of quality of life in patients with psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Germany; Humans; Male; Middle Aged; Patient Satisfaction; Prevalence; Psoriasis; Quality of Life; Risk Factors; Treatment Outcome | 2013 |
Psoriasis plaque test with confocal microscopy: evaluation of different microscopic response pathways in NSAID and steroid treated lesions.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Dermoscopy; Diclofenac; Drug Monitoring; Epidermis; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Microscopy, Confocal; Psoriasis; Treatment Outcome | 2013 |
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Psoriasis; Recurrence; Scalp Dermatoses; Young Adult | 2014 |
Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Calcium; Creatinine; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Psoriasis; Severity of Illness Index; Suspensions; Time Factors | 2013 |
Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.
Topics: Anti-Inflammatory Agents; Bandages; Betamethasone; Betamethasone Valerate; Calcitriol; Chronic Disease; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Single-Blind Method | 2014 |
Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2014 |
Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial.
Topics: Betamethasone; Calcitriol; Clinical Protocols; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Ointments; Outcome Assessment, Health Care; Psoriasis | 2014 |
Alternative treatment with calcipotriol plus betamethasone dipropionate gel in psoriasis vulgaris using a short-contact approach.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome; Young Adult | 2014 |
A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg/g ointment) when compared to betamethasone diproprionate ointment (64 mg/g) in patients with nail psoriasis.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Double-Blind Method; Female; Humans; Male; Nail Diseases; Ointments; Psoriasis; Treatment Outcome | 2014 |
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Preference; Prospective Studies; Psoriasis; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2015 |
Clearing of psoriasis documented by laser Doppler perfusion imaging contrasts remaining elevation of dermal expression levels of CD31.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Biomarkers; Blood Flow Velocity; Calcitriol; Cytokines; Dermatologic Agents; Drug Combinations; Female; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; NK Cell Lectin-Like Receptor Subfamily K; Ointments; Perfusion Imaging; Psoriasis; Reproducibility of Results; Sensitivity and Specificity; Skin; Up-Regulation | 2015 |
Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Patient Preference; Pilot Projects; Psoriasis; Severity of Illness Index; Suspensions; Treatment Outcome | 2014 |
Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
Topics: Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Single-Blind Method; Ultrasonography; Young Adult | 2015 |
Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
Topics: Administration, Topical; Adult; Asian People; Betamethasone; Calcitriol; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Safety; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Solutions; Treatment Outcome | 2016 |
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
Topics: Adult; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Single-Blind Method; Treatment Outcome | 2016 |
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).
Topics: Adolescent; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Psoriasis; Skin; Treatment Outcome; Young Adult | 2015 |
DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Delivery Systems; Emollients; Female; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome; Young Adult | 2016 |
Improvement in Extensive Moderate Plaque Psoriasis With a Novel Emollient Spray Formulation of Betamethasone Dipropionate 0.05.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Body Surface Area; Double-Blind Method; Emollients; Female; Glucocorticoids; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Skin; Treatment Outcome; Young Adult | 2016 |
Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Quality of Life; Recurrence; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2016 |
Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Pruritus; Psoriasis; Treatment Outcome; Visual Analog Scale; Young Adult | 2017 |
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.
Topics: Adult; Aerosols; Betamethasone; Calcitriol; Female; Gels; Humans; Male; Middle Aged; Psoriasis | 2017 |
Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled Studies.
Topics: Adolescent; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Drug Combinations; Drug Compounding; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Statistics as Topic; Treatment Outcome; Young Adult | 2016 |
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study.
Topics: Adult; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Drug Compounding; Female; Health Status; Humans; Male; Psoriasis; Quality of Life | 2016 |
A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Betamethasone; Calcitriol; China; Clinical Protocols; Data Interpretation, Statistical; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Models, Statistical; Psoriasis; Quality of Life; Recurrence; Remission Induction; Research Design; Skin; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2016 |
Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Male; Middle Aged; Prospective Studies; Pruritus; Psoriasis; Remission Induction; Republic of Korea; Severity of Illness Index | 2017 |
Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Calcitriol; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Combinations; Finland; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammation Mediators; Interleukin-17; Interleukin-23; Psoriasis; Receptors, Glucocorticoid; Signal Transduction; Skin; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
Topics: Adult; Aerosols; Betamethasone; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Single-Blind Method; Treatment Outcome | 2017 |
Vitamin D3 derivatives, alone or in combination with glucocorticoids, suppress streptococcal pyrogenic enterotoxin A-stimulated proliferation of peripheral blood mononuclear cells in patients with psoriasis.
Topics: Adult; Aged; Bacterial Toxins; Betamethasone; Cell Proliferation; Cholecalciferol; Cytokines; Female; Glucocorticoids; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Psoriasis | 2017 |
Treatment of nail psoriasis with Pulse Dye Laser plus calcipotriol betametasona gel vs. Nd:YAG plus calcipotriol betamethasone gel: An intrapatient left-to-right controlled study.
Topics: Adult; Aged; Betamethasone; Calcitriol; Combined Modality Therapy; Drug Combinations; Female; Gels; Humans; Lasers, Dye; Lasers, Solid-State; Low-Level Light Therapy; Male; Middle Aged; Nail Diseases; Prospective Studies; Psoriasis; Treatment Outcome | 2017 |
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2017 |
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Biomarkers; Cell Differentiation; Clobetasol; Cytokines; Dermatitis, Atopic; Female; Humans; Hyperplasia; Male; Middle Aged; Placebo Effect; Psoriasis; Skin; Tacrolimus; Young Adult | 2017 |
A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Physician-Patient Relations; Psoriasis; Quality of Life; Treatment Outcome; Young Adult | 2017 |
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Skin; Treatment Outcome | 2008 |
A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Canada; Denmark; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; France; Germany; Humans; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Prospective Studies; Psoriasis; Scalp; Severity of Illness Index; Treatment Outcome; United Kingdom | 2008 |
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome; Young Adult | 2009 |
[New perspectives in treatment of bounded forms of psoriasis].
Topics: Adolescent; Adult; Betamethasone; Calcitriol; Combined Modality Therapy; Drug Combinations; Electronarcosis; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Treatment Outcome; Young Adult | 2008 |
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis.
Topics: Adult; Betamethasone; Drug Administration Schedule; Eosine Yellowish-(YS); Female; Glucocorticoids; Humans; Keratolytic Agents; Male; Middle Aged; Patient Satisfaction; Psoriasis; Severity of Illness Index; Treatment Outcome | 2009 |
Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Quality of Life | 2009 |
Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Nail Diseases; Ointments; Psoriasis | 2009 |
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Young Adult | 2009 |
Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Psychology; Quality of Life; Scalp Dermatoses; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
Microcirculatory modifications of psoriatic lesions during topical therapy.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Capillaries; Dermatologic Agents; Dermoscopy; Drug Therapy, Combination; Female; Humans; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Psoriasis; Skin; Treatment Outcome; Young Adult | 2009 |
Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model.
Topics: Animals; Betamethasone; Biomarkers; Biopsy; Calcitriol; Dermatologic Agents; Disease Models, Animal; Drug Combinations; Endpoint Determination; Humans; Immunohistochemistry; Mice; Mice, SCID; Psoriasis; Skin; Skin Tests; Transplantation, Heterologous; Vitamin D | 2009 |
Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study.
Topics: Adolescent; Adult; Betamethasone; Biomarkers; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Epithelium; Humans; Psoriasis; Treatment Outcome; Young Adult | 2010 |
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
Topics: Adalimumab; Administration, Topical; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Male; Medication Adherence; Middle Aged; Psoriasis; Severity of Illness Index | 2010 |
Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Scalp; Young Adult | 2011 |
Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Prospective Studies; Psoriasis; Time Factors; Young Adult | 2010 |
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Black or African American; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Hispanic or Latino; Humans; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
Topics: Adalimumab; Administration, Topical; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Tumor Necrosis Factor-alpha | 2011 |
Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Dihydroxycholecalciferols; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Ointment Bases; Pharmaceutical Vehicles; Psoriasis; Severity of Illness Index; Treatment Outcome | 2011 |
Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Pilot Projects; Psoriasis; Severity of Illness Index; Young Adult | 2012 |
The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Budesonide; Calcitriol; Dermatologic Agents; Dihydroxycholecalciferols; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Pruritus; Psoriasis; Time Factors; Young Adult | 2011 |
Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Calcitriol; Contraceptives, Oral, Combined; Dermatologic Agents; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Male; Middle Aged; Pilot Projects; Psoriasis; Receptors, Tumor Necrosis Factor; Sample Size; Treatment Outcome | 2011 |
Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Middle Aged; Occlusive Dressings; Ointments; Psoriasis; Single-Blind Method; Treatment Outcome | 2011 |
Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Janus Kinase 1; Janus Kinase 2; Male; Middle Aged; Nitriles; Pilot Projects; Psoriasis; Pyrazoles; Pyrimidines; Signal Transduction; Treatment Outcome; Young Adult | 2012 |
Combination therapy using maxacalcitol and corticosteroid lotions preliminary to monotherapy with maxacalcitol lotion for scalp psoriasis.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Skin Cream | 2014 |
Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Endpoint Determination; Female; Humans; Immunoglobulin A; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Quality of Life; Skin; Suspensions | 2013 |
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Psoriasis | 2002 |
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis | 2002 |
A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Reference Values; Severity of Illness Index; Sweden; Treatment Outcome | 2002 |
Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Combined Modality Therapy; Female; Humans; Male; Penicillins; Prospective Studies; Psoriasis; PUVA Therapy; Republic of North Macedonia; Retinoids; Treatment Outcome; Ultraviolet Therapy | 2002 |
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.
Topics: Adolescent; Betamethasone; Calcitriol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Pharmaceutical Vehicles; Prospective Studies; Psoriasis; Treatment Outcome | 2003 |
Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Europe; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome | 2003 |
The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment.
Topics: Adult; Atrophy; Betamethasone; Biopsy, Needle; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Skin; Ultrasonography | 2003 |
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
Topics: Anti-Inflammatory Agents; Antigens, CD; Betamethasone; Calcitriol; Cell Division; Dermis; Drug Therapy, Combination; Epidermis; Humans; Keratins; Ointments; Psoriasis; Skin; T-Lymphocyte Subsets; T-Lymphocytes | 2004 |
Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Clobetasol; Dermatitis, Atopic; Female; Honey; Humans; Male; Middle Aged; Olive Oil; Plant Oils; Psoriasis; Single-Blind Method; Waxes | 2003 |
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Canada; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Europe; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Severity of Illness Index | 2004 |
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
Topics: Activities of Daily Living; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Disability Evaluation; Double-Blind Method; Drug Combinations; Female; Health Status Indicators; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Quality of Life; Treatment Outcome | 2004 |
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Confidence Intervals; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Psoriasis; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Confidence Intervals; Cost-Benefit Analysis; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Costs; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Probability; Psoriasis; Reference Values; Risk Factors; Severity of Illness Index; Treatment Outcome | 2005 |
Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
Topics: Adolescent; Adult; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 2005 |
Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2006 |
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Eruptions; Female; Humans; Male; Middle Aged; Psoriasis; Severity of Illness Index | 2006 |
Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Topics: Administration, Cutaneous; Alefacept; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Therapy, Combination; Humans; Injections, Intramuscular; Prospective Studies; Psoriasis; Recombinant Fusion Proteins; Severity of Illness Index; Treatment Outcome | 2006 |
Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chi-Square Distribution; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Treatment Outcome | 2006 |
Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Humans; Laser Therapy; Male; Middle Aged; Psoriasis; Treatment Outcome | 2006 |
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
Topics: Alefacept; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Etanercept; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ointments; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retrospective Studies; Severity of Illness Index | 2006 |
1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcineurin Inhibitors; Calcitriol; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Peptidylprolyl Isomerase; Psoriasis; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2006 |
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Safety; Time Factors; Treatment Outcome | 2006 |
Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Topics: Administration, Topical; Adult; Alefacept; Anti-Inflammatory Agents; Antigens, CD; Betamethasone; Cell Differentiation; Cell Proliferation; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Epidermis; Humans; Immunohistochemistry; Injections, Intramuscular; Keratinocytes; Psoriasis; Recombinant Fusion Proteins; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome | 2007 |
Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Compliance; Patient Dropouts; Pilot Projects; Pruritus; Psoriasis; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Germany; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Models, Theoretical; Psoriasis | 2007 |
Methotrexate-betamethasone weekly oral pulse in psoriasis.
Topics: Administration, Oral; Adolescent; Adult; Betamethasone; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Severity of Illness Index; Treatment Outcome | 2007 |
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2007 |
Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Patient Satisfaction; Probability; Prospective Studies; Psoriasis; Reference Values; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2008 |
Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Severity of Illness Index; Single-Blind Method | 2008 |
Betamethasone 17-valerate. A custom-made topical corticosteroid.
Topics: Betamethasone; Dermatitis; Dermatitis, Contact; Dosage Forms; Eczema; Fluocinolone Acetonide; Granuloma; Hand Dermatoses; Humans; Lichen Planus; Psoriasis; Skin Diseases | 1967 |
Comparison of betamethasone 17-valerate ointment with fluocortolone and fluocortolone caproate ointment.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Caproates; Child; Child, Preschool; Eczema; Female; Humans; Hydrocortisone; Infant; Male; Middle Aged; Ointments; Psoriasis; Valerates | 1967 |
Comparison of two application schedules for clobetasol 17 propionate.
Topics: Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Drug Administration Schedule; Humans; Psoriasis; Random Allocation; Time Factors | 1982 |
The effect on psoriasis of clobetasol propionate used alone or in combination with UVB.
Topics: Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Male; Photochemotherapy; Psoriasis; Recurrence; Time Factors; Ultraviolet Therapy | 1984 |
Systemic side-effects of three topical steroids in diseased skin.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Budesonide; Clinical Trials as Topic; Dermatitis, Exfoliative; Female; Glucocorticoids; Humans; Male; Middle Aged; Pregnenediones; Psoriasis | 1983 |
[Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis; Dermatitis, Seborrheic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eczema; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid | 1983 |
Halomethasone (C 48.401-Ba) for the topical treatment of common dermatoses.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Seborrheic; Double-Blind Method; Humans; Psoriasis | 1984 |
A comparative multicentre trial of halometasone ointment and fluocortolone plus fluocortolone caproate ointment in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Female; Fluocortolone; Humans; Male; Middle Aged; Ointments; Psoriasis | 1983 |
Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1983 |
Clinical evaluation on the long-term use of halometasone ointment in chronic eczema and psoriasis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clinical Trials as Topic; Eczema; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1983 |
[Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
Topics: Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Humans; Photochemotherapy; Psoriasis; PUVA Therapy | 1983 |
Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis | 1983 |
Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
Topics: Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Psoriasis; Random Allocation | 1984 |
[Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1984 |
Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Betamethasone; Female; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1984 |
Comparison of topical treatment with desoxymethasone solution 0.25% with salicylic acid 1% and betamethasone valerate solution 0.1% in patients with psoriasis of the scalp.
Topics: Administration, Topical; Betamethasone; Betamethasone Valerate; Consumer Behavior; Double-Blind Method; Female; Humans; Male; Psoriasis; Random Allocation; Scalp Dermatoses; Solutions | 1984 |
A double-blind trial of budesonide and betamethasone- 17,21-dipropionate in psoriasis.
Topics: Adolescent; Adult; Aged; Betamethasone; Budesonide; Child; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Occlusive Dressings; Pregnenediones; Psoriasis | 1982 |
Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
Topics: Administration, Topical; Betamethasone; Clinical Trials as Topic; Clobetasol; Drug Administration Schedule; Humans; Psoriasis | 1982 |
Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Female; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Tretinoin | 1982 |
Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Drug Evaluation; Drug Interactions; Drug Synergism; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Scalp Dermatoses | 1983 |
Once-daily treatment of psoriasis with topical glucocorticosteroid ointments.
Topics: Administration, Topical; Adult; Betamethasone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Ointments; Psoriasis | 1983 |
Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
Topics: Administration, Topical; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Propylene Glycols; Psoriasis | 1980 |
Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Eczema; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Psoriasis | 1981 |
A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis.
Topics: Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Budesonide; Child; Clinical Trials as Topic; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Pregnenediones; Psoriasis | 1981 |
[Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Clobetasol; Desoximetasone; Diflucortolone; Double-Blind Method; Eczema; Humans; Middle Aged; Neurodermatitis; Psoriasis | 1981 |
Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Scalp Dermatoses; Time Factors | 1981 |
Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Cresols; Drug Combinations; Erythema; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Psoriasis; Time Factors | 1982 |
Alclometasone dipropionate in psoriasis: a clinical study.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Drug Evaluation; Humans; Methylprednisolone; Psoriasis | 1982 |
Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
Topics: Anti-Inflammatory Agents; Betamethasone; Clobetasol; Drug Evaluation; Female; Humans; Hydrocortisone; Male; Psoriasis; Salicylates; Scalp Dermatoses; Suspensions | 1982 |
Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis.
Topics: Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Desoximetasone; Dexamethasone; Female; Humans; Hydrocortisone; Male; Middle Aged; Pituitary-Adrenal System; Psoriasis | 1981 |
Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Psoriasis; Salicylates; Salicylic Acid | 1994 |
Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Psoriasis | 1993 |
Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Esthetics; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis | 1993 |
Topical 0.05% betamethasone dipropionate: efficacy in psoriasis with once a day vs. twice a day application.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Psoriasis; Treatment Outcome | 1995 |
Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Female; Fluticasone; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis | 1996 |
Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Atrophy; Betamethasone; Blotting, Western; Double-Blind Method; Drug Therapy, Combination; Epidermis; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Tretinoin | 1996 |
Augmented betamethasone: efficacy in psoriasis with different dosing frequencies.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Ointments; Pharmaceutical Vehicles; Psoriasis; Remission Induction | 1996 |
Calcipotriol in psoriasis vulgaris: a controlled trial comparing betamethasone dipropionate + salicylic acid.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Patient Compliance; Psoriasis; Salicylates; Salicylic Acid; Treatment Outcome | 1997 |
Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Administration Schedule; Female; Flurandrenolone; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Psoriasis; Treatment Outcome | 1998 |
Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Psoriasis; Treatment Outcome | 1998 |
Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Nail Diseases; Ointments; Psoriasis; Salicylates | 1998 |
[Diprosalic in the therapy of psoriasis and atopic dermatitis].
Topics: Adolescent; Adult; Betamethasone; Child; Dermatitis, Atopic; Dermatologic Agents; Drug Combinations; Humans; Middle Aged; Ointments; Psoriasis; Remission Induction; Salicylates; Solutions; Time Factors | 1999 |
Tacrolimus ointment improves psoriasis in a microplaque assay.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Psoriasis; Skin Tests; Statistics, Nonparametric; Tacrolimus | 1999 |
Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Prospective Studies; Psoriasis; Surveys and Questionnaires; Tachyphylaxis | 1999 |
The value of colloid dressings in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Colloids; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Occlusive Dressings; Psoriasis; Treatment Outcome | 1999 |
Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Single-Blind Method; Treatment Outcome | 2000 |
Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study.
Topics: Adult; Aged; Betamethasone; Calcitriol; Cell Cycle; Cell Division; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Flow Cytometry; Humans; Keratin-10; Keratins; Male; Middle Aged; Psoriasis; Skin; Vimentin | 2001 |
Analysis of a new highly active corticosteroid.
Topics: Betamethasone; Clinical Trials as Topic; Dermatitis, Seborrheic; Drug Evaluation; Female; Humans; Male; Psoriasis | 1976 |
Investigations of a new synthetic steroid, betame thasone-17, 21-dipropionate, in alcoholic solution.
Topics: Adult; Betamethasone; Clinical Trials as Topic; Dermatitis, Seborrheic; Female; Humans; Hydrocortisone; Male; Middle Aged; Propionates; Psoriasis; Time Factors; Valerates; Vasoconstrictor Agents | 1975 |
A comparison of betamethasone benzoate gel and betamethasone valerate cream.
Topics: Betamethasone; Dermatitis, Seborrheic; Drug Evaluation; Eczema; Gels; Humans; Micelles; Neurodermatitis; Psoriasis; Skin Diseases | 1976 |
A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate.
Topics: Betamethasone; Cell Count; Clinical Trials as Topic; Clobetasol; Eczema; Flurandrenolone; Humans; Psoriasis; Skin | 1977 |
Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Dermatitis, Atopic; Double-Blind Method; Humans; Hydrocortisone; Occlusive Dressings; Pituitary-Adrenal System; Pregnenediones; Psoriasis | 1977 |
Tibicorten and betamethasone valerate: a double-blind comparative study.
Topics: Acute Disease; Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Child; Chronic Disease; Clinical Trials as Topic; Eczema; Female; Humans; Male; Middle Aged; Psoriasis; Triamcinolone Acetonide | 1977 |
Local treatment of psoriasis with desoxymethasone and betamethasone 17,21-dipropionate: a double-blind comparison.
Topics: Administration, Topical; Adolescent; Betamethasone; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Female; Humans; Male; Psoriasis | 1977 |
Psoriasis treated with clobetasol propionate and photochemotherapy.
Topics: Adult; Betamethasone; Clinical Trials as Topic; Clobetasol; Drug Therapy, Combination; Female; Humans; Methoxsalen; Photochemotherapy; Placebos; Psoriasis | 1978 |
[Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
Topics: Administration, Topical; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Drug Evaluation; Humans; Hydrocortisone; Pituitary-Adrenal System; Psoriasis | 1978 |
Pharmacological effects of glucocorticoid on arachidonic acid content of lesions of psoriasis.
Topics: Adult; Arachidonic Acids; Betamethasone; Clinical Trials as Topic; Female; Humans; Hydroxy Acids; Male; Psoriasis; Skin | 1978 |
A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment.
Topics: Adrenal Cortex Hormones; Adult; Betamethasone; Clinical Trials as Topic; Clobetasol; Dermatitis, Atopic; Double-Blind Method; Eczema; Female; Humans; Male; Middle Aged; Psoriasis | 1978 |
Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients.
Topics: Adrenal Cortex Hormones; Betamethasone; Clinical Trials as Topic; Clobetasol; Depression, Chemical; Double-Blind Method; Humans; Hydrocortisone; Psoriasis | 1978 |
A double-blind controlled evaluation of diprosone cream 0.05% in comparison with synalar cream 0.01% in the treatment of psoriasis and other steroid responsive dermatoses.
Topics: Betamethasone; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Fluocinolone Acetonide; Humans; Ointments; Psoriasis | 1978 |
Influence of the base on the results of clinical trials with topical corticosteroids.
Topics: Administration, Topical; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Eczema; Halcinonide; Humans; Ointments; Psoriasis; Skin Diseases | 1979 |
A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Double-Blind Method; Eczema; Female; Fluocinolone Acetonide; Humans; Male; Middle Aged; Psoriasis; Random Allocation | 1979 |
[Comparative study of clobetasol 17-propionate and traimcinolone acetonide].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Skin Diseases; Solutions; Triamcinolone Acetonide | 1979 |
Treatment of psoriasis: comparative study using allantoin coal tar extract combined with hydrocortisone and betamethasone valerate.
Topics: Adolescent; Adult; Aged; Allantoin; Betamethasone; Betamethasone Valerate; Coal Tar; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hydrocortisone; Male; Middle Aged; Psoriasis | 1979 |
Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate.
Topics: Adult; Betamethasone; Betamethasone Valerate; Evaluation Studies as Topic; Female; Humans; Male; Methoxsalen; Middle Aged; Photochemotherapy; Psoriasis; Ultraviolet Therapy | 1979 |
The comparative efficacy of betamethasone dipropionate cream and ointment formulations in the treatment of psoriasis.
Topics: Betamethasone; Chronic Disease; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1979 |
The clinical assessment of topical corticosteroid activity.
Topics: Adrenal Cortex Hormones; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Eczema; Fluocinolone Acetonide; Flurandrenolone; Humans; Hydrocortisone; Occlusive Dressings; Psoriasis; Triamcinolone Acetonide; Vasoconstrictor Agents | 1976 |
The response of psoriasis to betamethasone valerate and clobetasol propionate. A 6-month controlled study.
Topics: Adult; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Female; Humans; Hydrocortisone; Male; Middle Aged; Psoriasis; Remission, Spontaneous | 1976 |
Betamethasone dipropionate cream for the treatment of psoriasis. A collaborative evaluation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Child; Child, Preschool; Clinical Trials as Topic; Female; Fluocinolone Acetonide; Humans; Male; Middle Aged; Ointments; Psoriasis | 1976 |
[Comparison between 2 steroid dosage forms in psoriasis and eczema].
Topics: Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Dexamethasone; Drug Evaluation; Eczema; Female; Humans; Male; Middle Aged; Psoriasis | 1975 |
Percutaneous absorption of betamethasone 17-benzoate measured by radioimmunoassay.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Eczema; Female; Gels; Hospitalization; Humans; Hydrocortisone; Male; Middle Aged; Prurigo; Psoriasis; Radioimmunoassay; Skin Absorption | 1976 |
Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis.
Topics: Betamethasone; Clinical Trials as Topic; Eczema; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Psoriasis | 1976 |
Betamethasone dipropionate ointment in the treatment of psoriasis and atopic dermatitis: a double-blind study.
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis, Atopic; Drug Evaluation; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1976 |
Multicenter trial analysis. Fluocinonide and betamethasone gel in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Child; Child, Preschool; Clinical Trials as Topic; Female; Fluocinolone Acetonide; Fluocinonide; Gels; Humans; Male; Middle Aged; Psoriasis | 1976 |
Relapse rate of psoriasis worsened by adding steroids to a dithranol regime.
Topics: Anthracenes; Anthralin; Betamethasone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Psoriasis; Recurrence | 1976 |
Local treatment of psoriasis of the scalp with clobetasol propionate and betamethasone-17,21-dipropionate: a double-blind comparison.
Topics: Betamethasone; Clinical Trials as Topic; Clobetasol; Humans; Psoriasis; Scalp Dermatoses | 1976 |
An evaluation of betamethasone dipropionate (Diprosone) versus Locacorten 0.02% cream.
Topics: Administration, Topical; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Drug Evaluation; Flumethasone; Humans; Psoriasis | 1976 |
Percutaneous absorption of betamethasone-17, 21-dipropionate and salicylic acid during the treatment of psoriasis and eczema.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Eczema; Female; Humans; Hydrocortisone; Male; Middle Aged; Psoriasis; Salicylates; Skin Absorption; Time Factors | 1976 |
Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Flumethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Male; Middle Aged; Neurodermatitis; Psoriasis; Skin Diseases; Vasomotor System | 1976 |
A double-blind evaluation of betamethasone-17, 21-dipropionate (Diproderm ointment) in comparison with fluclorolone acetonide (Topilar ointment) in psoriasis.
Topics: Betamethasone; Clinical Trials as Topic; Drug Evaluation; Humans; Pregnadienetriols; Propionates; Psoriasis; Time Factors | 1975 |
Betamethasone valerate ointment compared with fluocinonide FAPG.
Topics: Betamethasone; Dosage Forms; Eczema; Fluocinonide; Humans; Ointments; Psoriasis | 1977 |
Therapy of resistant psoriasis with topical corticosteroids and dimethylsulfoxide.
Topics: Administration, Topical; Adult; Betamethasone; Betamethasone Valerate; Dimethyl Sulfoxide; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Ointments; Psoriasis | 1976 |
double-blind"double-bind.
Topics: Adolescent; Adult; Betamethasone; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Ointments; Propionates; Psoriasis; Steroids, Chlorinated; Valerates | 1975 |
Controlled double-blind comparative trial with fluprednylidene acetate cream and its base.
Topics: Acetates; Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Eczema; Female; Fluprednisolone; Glucocorticoids; Humans; Lichen Planus; Male; Pemphigus; Placebos; Psoriasis; Skin Diseases; Valerates | 1975 |
Clinical evaluation of desoximetasone in treatment of dermatoses and psoriasis.
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Corticosterone; Dexamethasone; Drug Evaluation; Female; Humans; Male; Middle Aged; Psoriasis; Skin Diseases; Triamcinolone Acetonide; Valerates | 1975 |
Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Female; Glucocorticoids; Humans; Male; Middle Aged; Occlusive Dressings; Ointments; Pregnenediones; Psoriasis; Steroids, Chlorinated; Steroids, Fluorinated; Valerates | 1975 |
Double-blind comparison between two new topical corticosteroids, halcinonide 0.1% and clobetasol propionate cream 0.05%.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Eczema; Glucocorticoids; Humans; Pregnenediones; Psoriasis | 1975 |
Betamethasone dipropionate in psoriasis and atopic dermatitis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dermatitis, Atopic; Humans; Hydrocortisone; Ointments; Psoriasis | 1976 |
Comparison of the response of psoriasis, over a 6-month period, to clobetasol propionate and fluocinolone acetonide ointments.
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Female; Fluocinolone Acetonide; Humans; Male; Middle Aged; Psoriasis; Recurrence | 1975 |
[Clinical experiences with a new topical steroid].
Topics: Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Child; Child, Preschool; Dermatitis; Dexamethasone; Drug Evaluation; Eczema; Humans; Infant; Middle Aged; Neurodermatitis; Psoriasis | 1975 |
Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betamethasone valerate.
Topics: Adult; Aged; Antigen-Presenting Cells; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Betamethasone; Calcitriol; Dendritic Cells; Epidermis; Female; Humans; Keratins; Male; Middle Aged; Psoriasis; T-Lymphocytes | 1992 |
Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Chronic Disease; Emollients; Female; Humans; Male; Middle Aged; Oils; Psoriasis; Water | 1992 |
Calcipotriol and betamethasone valerate for psoriasis.
Topics: Betamethasone; Calcitriol; Double-Blind Method; Humans; Psoriasis | 1991 |
DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 analogue MC903 and betamethasone.
Topics: Adult; Aged; Antibodies, Monoclonal; Betamethasone; Calcitriol; DNA; Double-Blind Method; Female; Fluorescent Antibody Technique; Humans; Keratins; Male; Middle Aged; Psoriasis; Skin | 1990 |
[Evaluation of the effect of local corticosteroids in the phototherapy of psoriasis].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Combined Modality Therapy; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Ultraviolet Therapy | 1991 |
A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clobetasol; Double-Blind Method; Female; Germany; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Remission Induction; Vasoconstrictor Agents; Wound Healing | 1991 |
Intermittent corticosteroid maintenance treatment of psoriasis: a double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimen.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis; Time Factors | 1991 |
Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris.
Topics: Adult; Betamethasone; Dermatitis, Atopic; Double-Blind Method; Drug Carriers; Female; Humans; Liposomes; Male; Psoriasis | 1990 |
[The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Betamethasone; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Psoriasis; Randomized Controlled Trials as Topic | 1990 |
Therapeutic response to a dermatologic patch and betamethasone valerate 0.1 percent cream in the management of chronic plaques in psoriasis.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Colloids; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Occlusive Dressings; Psoriasis | 1990 |
A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. The Actiderm Multi-Center Study Group.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Betamethasone; Chronic Disease; Female; Halcinonide; Humans; Male; Middle Aged; Multicenter Studies as Topic; Occlusive Dressings; Pharmaceutical Vehicles; Psoriasis; Triamcinolone Acetonide | 1990 |
The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis.
Topics: Adult; Betamethasone; Body Surface Area; Double-Blind Method; Female; Fish Oils; Humans; Male; Middle Aged; Plant Oils; Psoriasis | 1990 |
Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Ointments; Psoriasis | 1990 |
0.05 percent betamethasone dipropionate in optimized cream vehicle for psoriasis.
Topics: Adolescent; Adult; Betamethasone; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Ointment Bases; Psoriasis | 1989 |
Preatrophy: covert sign of thinned skin.
Topics: Adult; Aged; Atrophy; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Random Allocation; Skin | 1989 |
A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Eczema; Glucocorticoids; Humans; Middle Aged; Psoriasis | 1989 |
Antipsoriatic effect of local corticosteroids--O2-consumption and blood flow measurements compared to clinical parameters.
Topics: Adolescent; Adult; Aged; Bandages, Hydrocolloid; Betamethasone; Clinical Trials as Topic; Clobetasol; Colloids; Female; Humans; Male; Middle Aged; Occlusive Dressings; Oxygen Consumption; Psoriasis; Skin; Skin Temperature | 1989 |
[Treatment with topical corticosteroids in severe or resistant dermatoses].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Seborrheic; Desoximetasone; Dexamethasone; Double-Blind Method; Drug Tolerance; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis; Safety; Skin Diseases; Time Factors | 1985 |
Psoriasis of the scalp treated with Grenz rays or topical corticosteroid combined with Grenz rays. A comparative randomized trial.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Combined Modality Therapy; Glucocorticoids; Humans; Middle Aged; Psoriasis; Random Allocation; Scalp Dermatoses | 1988 |
[Double-blind evaluation of the effectiveness and tolerance of tipredane cream and betamethasone valerate cream in patients with psoriasis].
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Chemical Phenomena; Chemistry; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Psoriasis | 1988 |
Additional effect of grenz rays on psoriasis lesions of the scalp treated with topical corticosteroids.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Humans; Middle Aged; Psoriasis; Scalp Dermatoses | 1987 |
Clinical and histologic heterogeneity of psoriatic plaques. Therapeutic relevance.
Topics: Administration, Topical; Betamethasone; Biopsy; Clobetasol; Drug Resistance; Humans; Hypertrophy; Psoriasis; Steroids; Triamcinolone | 1988 |
Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Betamethasone; Chronic Disease; Clobetasol; Coal Tar; Combined Modality Therapy; Drug Combinations; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Random Allocation; Staphylococcal Skin Infections; Ultraviolet Therapy | 1988 |
A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Drug Tolerance; Follow-Up Studies; Glucocorticoids; Humans; Ointments; Psoriasis; Time Factors | 1986 |
Clobetasol--a potent new topical corticosteroid.
Topics: Administration, Topical; Adrenal Insufficiency; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Clobetasol; Costs and Cost Analysis; Glucocorticoids; Humans; Psoriasis; Skin Diseases | 1986 |
Clobetasol propionate cream versus halcinonide cream in psoriasis.
Topics: Betamethasone; Clinical Trials as Topic; Clobetasol; Consumer Behavior; Double-Blind Method; Evaluation Studies as Topic; Halcinonide; Humans; Ointments; Pregnenediones; Psoriasis; Random Allocation | 1986 |
Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
Topics: Administration, Topical; Adolescent; Adrenal Glands; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Psoriasis; Random Allocation | 1987 |
Intermittent application of clobetasol-17-propionate in psoriasis.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Betamethasone; Clobetasol; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Psoriasis; Random Allocation | 1987 |
Betamethasone dipropionate in optimized vehicle. Intermittent pulse dosing for extended maintenance treatment of psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Random Allocation | 1987 |
Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate.
Topics: Administration, Topical; Adult; Anthracenes; Anthralin; Betamethasone; Clobetasol; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Psoriasis; Recurrence; Time Factors; Ultraviolet Therapy | 1986 |
The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
Topics: Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Pregnadienes; Psoriasis; Random Allocation | 1985 |
Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Random Allocation; Triamcinolone | 1985 |
Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Eczema; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Time Factors | 1985 |
Betamethasone dipropionate cream for the treatment of psoriasis. A double-blind comparison with clobetasol propionate cream.
Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Psoriasis | 1985 |
Application of topical corticosteroids.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Betamethasone Valerate; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psoriasis | 1985 |
The psoriasis bio-assay for topical corticosteroid activity.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Biological Assay; Female; Fluocinolone Acetonide; Flurandrenolone; Glucocorticoids; Humans; Hydrocortisone; Male; Methods; Occlusive Dressings; Psoriasis; Skin Tests; Time Factors | 1972 |
Skin colour changes in psoriasis responding to treatment with betamethasone-17-valerate under occlusion.
Topics: Betamethasone; Humans; Male; Occlusive Dressings; Pigmentation; Psoriasis; Skin; Spectrophotometry, Ultraviolet; Valerates | 1973 |
Treating psoriasis of the scalp with a new corticosteroid lotion.
Topics: Betamethasone; Clinical Trials as Topic; Humans; Psoriasis; Scalp Dermatoses; Valerates | 1974 |
Comparison of steroids in topical treatment of psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Female; Fluocinolone Acetonide; Humans; Male; Ointments; Psoriasis | 1967 |
Plethysmographic recordings of skin pulses. II. Piezoelectric and photoelectric measurements in psoriasis.
Topics: Betamethasone; Electricity; Electronics, Medical; Epinephrine; Humans; Injections, Intradermal; Light; Methacholine Compounds; Methods; Ointments; Photometry; Placebos; Plethysmography; Pressure; Psoriasis; Pulse; Skin; Valerates | 1970 |
Local treatment of psoriasis and eczema with betamethasone-17,21-dipropionate (Diproderm cream): a double-blind comparsion with fluocortolone caproate, fluocortolone pivalate (Ultralanum cream).
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Eczema; Female; Humans; Ketosteroids; Male; Middle Aged; Pregnadienediols; Psoriasis; Steroids, Fluorinated; Time Factors | 1974 |
Comparison of fluocinonide in a double-blind study with betamethasone valerate.
Topics: Acetates; Betamethasone; Dermatitis, Atopic; Dermatitis, Seborrheic; Drug Compounding; Eczema; Fluocinolone Acetonide; Humans; Ointments; Psoriasis; Time Factors; Valerates | 1972 |
Metosyn--a new steroid for topical use.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis, Seborrheic; Eczema; Glucocorticoids; Humans; Hydroxycorticosteroids; Psoriasis | 1972 |
A national double-blind clinical trial of a new corticosteroid lotion: a 12-investigator cooperative analysis.
Topics: 1-Propanol; Adolescent; Adult; Aged; Betamethasone; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis, Seborrheic; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Placebos; Pruritus; Psoriasis; Scalp; Valerates | 1972 |
Selective evaluation of a new topical steroid (betamethasone benzoate).
Topics: Administration, Topical; Anti-Inflammatory Agents; Benzoates; Betamethasone; Child; Clinical Trials as Topic; Dermatitis, Seborrheic; Eczema; Glucocorticoids; Humans; Male; Placebos; Psoriasis; Skin Diseases | 1973 |
Ultralanum.
Topics: Adrenal Cortex Hormones; Benzimidazoles; Betamethasone; Hexachlorophene; Histamine H1 Antagonists; Humans; Psoriasis | 1967 |
Multi-investigator cooperative comparative studies in clinical research.
Topics: Betamethasone; Clinical Trials as Topic; Fluocinolone Acetonide; Humans; Medical History Taking; Methods; Pharmaceutical Vehicles; Psoriasis; Research; Research Personnel | 1972 |
"Metosyn" in psoriasis and eczema.
Topics: Betamethasone; Clinical Trials as Topic; Eczema; Fluocinolone Acetonide; Humans; Occlusive Dressings; Psoriasis | 1972 |
Retinoic acid in the treatment of psoriasis.
Topics: Betamethasone; Clinical Trials as Topic; Humans; Male; Ointments; Psoriasis; Vitamin A | 1972 |
Clinical trial of fluclorolone acetonide, a new topical steroid.
Topics: Anti-Inflammatory Agents; Betamethasone; Chlorine; Clinical Trials as Topic; Eczema; Fluorine; Glucocorticoids; Humans; Ointments; Psoriasis | 1972 |
Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.
Topics: Adolescent; Adult; Aged; Benzoates; Betamethasone; Child; Clinical Trials as Topic; Dermatitis; Eczema; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Skin Diseases; Valerates | 1972 |
Topical vitamin A acid in the treatment of psoriasis.
Topics: Adolescent; Adult; Betamethasone; Carotenoids; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Humans; Male; Middle Aged; Occlusive Dressings; Ointments; Placebos; Plastics; Psoriasis; Recurrence; Skin; Vitamin A | 1973 |
Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
Topics: Acetals; Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis; Fluocinolone Acetonide; Flurandrenolone; Forearm; Humans; Hydrocortisone; Lichen Planus; Prednisolone; Psoriasis; Triamcinolone Acetonide; Vasoconstrictor Agents | 1973 |
Treatment of localized skin lesions with betamethasone 17-valerate and triamcinolone acetonide in alcoholic solution under occlusive dressing. A double blind comparative study.
Topics: 1-Propanol; Adolescent; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Drug Combinations; Eczema; Ethanol; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Occlusive Dressings; Psoriasis; Skin Diseases; Solutions; Triamcinolone Acetonide; Valerates | 1972 |
A preliminary clinical trial of hydrocortisone-17-butyrate.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Butyrates; Child; Child, Preschool; Clinical Trials as Topic; Dermatologic Agents; Eczema; Female; Humans; Hydrocortisone; Hydroxycorticosteroids; Male; Middle Aged; Psoriasis | 1973 |
Topical corticosteroids: a comparison in the treatment of eczema and psoriasis in general practice.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Eczema; Family Practice; Female; Formates; Humans; Hydroxycorticosteroids; Ketosteroids; Male; Ointments; Pregnadienes; Psoriasis; Time Factors | 1973 |
Betamethasone 17-valerate ointment in a lanolin-free base.
Topics: Administration, Topical; Betamethasone; Clinical Trials as Topic; Dermatitis, Contact; Dermatologic Agents; Eczema; Fluocinolone Acetonide; Humans; Lanolin; Ointments; Pharmaceutical Vehicles; Propylene Glycols; Psoriasis; Steroids, Chlorinated; Valerates | 1973 |
The treatment of psoriasis with fluocinonide. A comparative double-blind clinical trial with betamethasone valerate.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Female; Humans; Hydroxycorticosteroids; Male; Middle Aged; Pregnanes; Psoriasis; Time Factors | 1974 |
The clinical evaluation of a new topical corticosteroid, clobetasol propionate. An international controlled trial.
Topics: Acetates; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Eczema; Fluocinolone Acetonide; Humans; Methods; Ointments; Propionates; Psoriasis; Steroids, Chlorinated; Structure-Activity Relationship | 1974 |
Halcinonide in the treatment of corticosteroid responsive dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Clinical Trials as Topic; Dermatitis, Atopic; Eczema; Edema; Erythema; Female; Humans; Male; Middle Aged; Neurodermatitis; Pain; Pharmaceutical Vehicles; Pregnenediones; Pruritus; Psoriasis; Skin Diseases; Steroids, Chlorinated; Steroids, Fluorinated; Structure-Activity Relationship; Triamcinolone Acetonide | 1974 |
Letter: Preliminary trial of desonide, a new topical corticosteroid.
Topics: Acetals; Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Eczema; Humans; Ketosteroids; Pregnadienetriols; Psoriasis | 1974 |
A comparison of the effect of various topically active steroids on the clinical and histological features of psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Biopsy; Chlorine; Clinical Trials as Topic; Collagen; Female; Fluocinolone Acetonide; Fluorine; Glucocorticoids; Humans; Male; Mitosis; Occlusive Dressings; Psoriasis; Skin; Time Factors | 1973 |
[A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].
Topics: Betamethasone; Clinical Trials as Topic; Fluocinolone Acetonide; Humans; Psoriasis; Valerates | 1974 |
Diprosone ointment in psoriasis. A double-blind trial.
Topics: Betamethasone; Clinical Trials as Topic; Fluocinolone Acetonide; Humans; Ointments; Propionates; Psoriasis; Steroids, Chlorinated | 1974 |
A double-blind comparison of fluocinonide and betamethasone valerate ointments.
Topics: Acetates; Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Fluocinolone Acetonide; Humans; Lichen Planus; Ointments; Psoriasis; Valerates | 1973 |
[A new steroid for the treatment of psoriasis and eczema].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Dermatitis, Contact; Eczema; Female; Glucocorticoids; Humans; Hydrocarbons, Chlorinated; Hydrocarbons, Fluorinated; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Psoriasis | 1973 |
Beclomethasone dipropionate compared with betamethasone-17-valerate in the treatment of inflammatory dermatoses.
Topics: Betamethasone; Clinical Trials as Topic; Eczema; Humans; Pregnanetriol; Psoriasis | 1970 |
[Controlled experimentation on the therapeutic effect of 2 topical anti-inflammatory steroids].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatitis; Female; Glucocorticoids; Humans; Male; Middle Aged; Pregnanes; Psoriasis; Skin Diseases | 1970 |
Comparative double-blind clinical trial of fluocinonide and betamethasone valerate.
Topics: Acetates; Betamethasone; Clinical Trials as Topic; Eczema; Esters; Evaluation Studies as Topic; Fatty Alcohols; Fluocinolone Acetonide; Glucocorticoids; Humans; Ointments; Pharmaceutical Vehicles; Propylene Glycols; Psoriasis; Valerates | 1971 |
Comparison of fluocinonide and betamethasone in the treatment of psoriasis and eczema.
Topics: Acetates; Betamethasone; Eczema; Esters; Evaluation Studies as Topic; Fatty Alcohols; Fluocinolone Acetonide; Humans; Ointments; Pharmaceutical Vehicles; Propylene Glycols; Psoriasis; Valerates | 1971 |
The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study.
Topics: Betamethasone; Chemistry, Pharmaceutical; Clinical Trials as Topic; Eczema; Fluocinolone Acetonide; Humans; Hydrocortisone; Pharmaceutical Vehicles; Psoriasis; Skin Absorption; Valerates | 1965 |
[Clinical experimentation of a new preparation: "betamethasone-17-valerate" for topical use].
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Eczema; Female; Humans; Middle Aged; Ointments; Psoriasis; Valerates | 1965 |
A comparative trial of full and half strength betamethasone 17-valerate cream.
Topics: Betamethasone; Clinical Trials as Topic; Eczema; Humans; Psoriasis | 1965 |
Betamethasone 17-valerate: a new alcoholic formulation for psoriasis of the scalp.
Topics: Adolescent; Adult; Aged; Alcohols; Betamethasone; Child; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Solutions | 1967 |
[Flubenisolonvalerate and fluocinolonacetonide in the treatment of skin diseases. A double-blind study].
Topics: Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Contact; Fluocinolone Acetonide; Humans; Psoriasis; Skin Diseases; Valerates | 1966 |
283 other study(ies) available for betamethasone and Psoriasis
| Article | Year |
|---|---|
A pruritic psoriatic plaque develops at the donor site of an autologous skin graft: Koebner phenomenon.
Topics: Anti-Inflammatory Agents; Betamethasone; Humans; Male; Middle Aged; Psoriasis; Skin Transplantation; Transplant Donor Site | 2021 |
Adjunctive Use of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Treated With Ixekizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 2022 |
Proactive vs. reactive psoriasis therapy: a long-term evaluation with dermoscopic and confocal microscopy assessment.
Topics: Adult; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Microscopy, Confocal; Psoriasis; Treatment Outcome | 2022 |
Sub-population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Greece; Humans; Patient Satisfaction; Psoriasis; Severity of Illness Index; Treatment Outcome | 2022 |
Transition of Topical Therapy Formulation in Psoriasis: Insights from a Canadian Practice Reflective.
Topics: Aerosols; Betamethasone; Canada; Dermatologic Agents; Drug Combinations; Humans; Ointments; Pruritus; Psoriasis; Quality of Life; Retrospective Studies; Treatment Outcome | 2022 |
The Maintenance Effect of Calcipotriene 0.05% and Betamethasone Dipropionate 0.064% (Cal/BD) Aerosol Foam in Combination With Apremilast.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Pilot Projects; Psoriasis; Thalidomide; Treatment Outcome | 2022 |
Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis.
Topics: Betamethasone; Gels; Humans; Nanoparticle Drug Delivery System; Psoriasis; Salicylic Acid; Scalp | 2022 |
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
Topics: Aerosols; Betamethasone; Consensus; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Recurrence; Treatment Outcome | 2022 |
Calcipotriol/betamethasone aerosol foam (Enstilum) for the topical treatment of psoriasis vulgaris in routine practice in Korea: A prospective, noninterventional, multicenter study of treatment outcomes and patient satisfaction.
Topics: Adult; Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Female; Humans; Immunoglobulin A; Male; Patient Satisfaction; Prospective Studies; Psoriasis; Quality of Life; Republic of Korea; Treatment Outcome | 2022 |
Betamethasone Dipropionate Derivatization, Biotransformation, Molecular Docking, and ADME Analysis as Glucocorticoid Receptor.
Topics: Betamethasone; Biotransformation; Dermatologic Agents; Humans; Molecular Docking Simulation; Psoriasis; Receptors, Glucocorticoid | 2022 |
The Effect of the Long-Term Calcipotriol/Betamethasone Dipropionate Local Therapy on Tissue Resident Memory Cells Markers in Psoriatic Eruptions.
Topics: Betamethasone; Calcitriol; Humans; Immunologic Memory; Interleukin-17; Psoriasis; Recurrence | 2022 |
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2022 |
Annual trends in Medicare part D prescription claims for calcipotriene/betamethasone dipropionate foam for psoriasis 2016-2020.
Topics: Aged; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Medicare Part D; Psoriasis; Treatment Outcome; United States | 2023 |
Expert Consensus on Real-World Use and Consumption Patterns of a Fixed-Dose Combination Foam for Psoriasis as a Reactive Management (RM) and Proactive Management (PAM) Regimen.
Topics: Betamethasone; Consensus; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Surveys and Questionnaires; Treatment Outcome | 2023 |
Prospective Observational Evaluation of Fixed Combination Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in the Management of Psoriasis with Scalp Involvement in Everyday Clinical Practice (the CAPITIS Study).
Topics: Adult; Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Prospective Studies; Pruritus; Psoriasis; Quality of Life; Scalp; Treatment Outcome | 2023 |
Fractional CO 2 Laser versus Fractional CO 2 Laser Plus Betamethasone/Calcipotriol Ointment in the Treatment of Nail Psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Humans; Nail Diseases; Ointments; Psoriasis; Treatment Outcome | 2023 |
Real-world efficacy of adjunctive calcipotriene/betamethasone dipropionate foam for recalcitrant psoriatic lesions on the scalp or lower legs with biologic therapy.
Topics: Betamethasone; Biological Products; Biological Therapy; Dermatologic Agents; Drug Combinations; Humans; Leg; Psoriasis; Retrospective Studies; Scalp; Treatment Outcome | 2023 |
INDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Emollients; Excipients; Humans; Psoriasis; Treatment Outcome | 2023 |
Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics.
Topics: Betamethasone; Biomarkers; Computational Biology; Humans; Proteomics; Psoriasis | 2023 |
INDIVIDUAL ARTICLE: Vehicles Matter: Calcipotriene and Betamethasone Dipropionate Foam as a Topical Psoriasis Therapy.
Topics: Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2023 |
Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Topics: Administration, Cutaneous; Animals; Betamethasone; Calcitriol; Cytokines; Dermatologic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression Regulation; Glucocorticoids; Humans; Imiquimod; Mice; Ointments; Psoriasis; Skin; Th1 Cells; Th17 Cells | 2020 |
A novel vehicle for the treatment of psoriasis.
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome | 2020 |
Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2021 |
Sensitivity of Different In Vitro Performance Tests and Their In Vivo Relevance for Calcipotriol/Betamethasone Ointment.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Evaluation; Drug Liberation; Female; Humans; In Vitro Techniques; Male; Ointments; Psoriasis; Random Allocation; Therapeutic Equivalency | 2020 |
Two cases of refractory nail psoriasis successfully treated with calcipotriol plus betamethasone dipropionate gel.
Topics: Administration, Oral; Aged; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Drug Combinations; Drug Resistance; Female; Gels; Humans; Male; Middle Aged; Nail Diseases; Ointments; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome | 2020 |
Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra-patient, left-to-right prospective study.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Lasers, Dye; Prospective Studies; Psoriasis; Treatment Outcome | 2020 |
Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis.
Topics: Animals; Betamethasone; Cell Survival; Cytokines; Dermatologic Agents; Disease Models, Animal; Gels; HaCaT Cells; Humans; Liposomes; Mice, Inbred BALB C; Particle Size; Pliability; Psoriasis; Rats; Rats, Sprague-Dawley; Tretinoin | 2020 |
Shear wave elastography and microvascular ultrasound in response evaluation to calcipotriol+betamethasone foam in plaque psoriasis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Elasticity Imaging Techniques; Feasibility Studies; Female; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome; Ultrasonography; Young Adult | 2021 |
Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Treatment Outcome | 2020 |
Guttate psoriasis secondary to COVID-19.
Topics: Adult; Betacoronavirus; Betamethasone; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Male; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2 | 2020 |
Grover's disease successfully treated with calcipotriene/betamethasone dipropionate ointment.
Topics: Acantholysis; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Ichthyosis; Ointments; Psoriasis | 2020 |
Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam for Plaque Psoriasis in Adolescents Aged 12-17 Years.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Psoriasis; Treatment Outcome | 2020 |
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matchi
Topics: Betamethasone; Calcitriol; Clobetasol; Humans; Nicotinic Acids; Psoriasis | 2020 |
Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adju
Topics: Betamethasone; Calcitriol; Clobetasol; Humans; Nicotinic Acids; Psoriasis | 2020 |
Hailey-Hailey disease treated successfully with calcipotriol plus betamethasone dipropionate aerosol foam: A case report.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Pemphigus, Benign Familial; Psoriasis; Treatment Outcome | 2021 |
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatologic Agents; Drug Combinations; Erythema; Female; Humans; Male; Middle Aged; Nicotinic Acids; Pain; Prospective Studies; Pruritus; Psoriasis; Recurrence; Retreatment; Severity of Illness Index; Skin Cream | 2021 |
Topical medications for chronic plaque psoriasis: A 3-year longitudinal study in France.
Topics: Administration, Topical; Betamethasone; Dermatologic Agents; France; Humans; Longitudinal Studies; Middle Aged; Psoriasis | 2021 |
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.
Topics: Adult; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Neoplasm Recurrence, Local; Psoriasis; Quality of Life | 2021 |
Efficacy and safety of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Treatment Outcome | 2021 |
Fixed-dose combination calcipotriol/betamethasone dipropionate foam provides a rapid onset of action, effective itch relief and improves patient quality of life.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life; Treatment Outcome | 2021 |
Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Treatment Outcome | 2021 |
Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost-effective.
Topics: Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Germany; Humans; Patient Satisfaction; Psoriasis; Quality of Life; Spain; Treatment Outcome | 2021 |
Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Ointments; Psoriasis; Treatment Outcome | 2021 |
A real-world, observational study on the effectiveness with calcipotriol/betamethasone aerosol foam in patients with plaque psoriasis in Greece: the CELSUS study.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Greece; Humans; Psoriasis; Treatment Outcome | 2021 |
Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Evaluation; Humans; Psoriasis; Treatment Outcome | 2021 |
Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.
Topics: Administration, Cutaneous; Animals; Betamethasone; Cytokines; Disease Models, Animal; Down-Regulation; Imiquimod; Male; Ointments; Psoriasis; Rats; Rats, Wistar; Severity of Illness Index; Signal Transduction; Skin; Transcriptome; Treatment Outcome; Up-Regulation | 2021 |
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Psoriasis; Treatment Outcome | 2021 |
A potential role of mesenchymal stem cells derived from human umbilical cord blood in ameliorating psoriasis-like skin lesion in the rats.
Topics: Animals; Betamethasone; Epidermis; Fetal Blood; Male; Mesenchymal Stem Cells; Psoriasis; Rats | 2022 |
Patient-reported outcomes with calcipotriol/betamethasone aerosol foam in patients with plaque psoriasis in Greece. Results from the CELSUS study.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Greece; Humans; Patient Reported Outcome Measures; Psoriasis; Treatment Outcome | 2021 |
Calcipotriene Plus Betamethasone Dipropionate Foam for Mild Psoriasis: Pooled Results from Three Randomized Trials.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Dosage Forms; Drug Combinations; Humans; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Management of patients with psoriasis.
Topics: Acitretin; Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Disease Management; Emollients; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Thalidomide | 2017 |
Economic burden of psoriatic patients in Japan: Analysis from a single outpatient clinic.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Aged; Ambulatory Care Facilities; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Biological Products; Calcitriol; Cost of Illness; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Female; Glucocorticoids; Humans; Japan; Male; Middle Aged; Psoriasis; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis.
Topics: Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Gels; Humans; Markov Chains; Netherlands; Ointments; Phototherapy; Psoriasis; Severity of Illness Index | 2017 |
Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Linear Models; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Patient Satisfaction; Psoriasis; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult | 2017 |
Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Topics: Adolescent; Adult; Aged; Anxiety; Betamethasone; Calcitriol; Depression; Dermatologic Agents; Female; Health Status; Health Surveys; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Psoriasis; Psychometrics; Quality of Life; Young Adult | 2017 |
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
Topics: Betamethasone; Biological Products; Budgets; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Models, Econometric; Psoriasis; Severity of Illness Index; United States | 2017 |
Patients with male gender or greater body weight use smaller amounts of topical therapy in psoriasis.
Topics: Administration, Topical; Adult; Betamethasone; Body Weight; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Sex Factors; Young Adult | 2018 |
Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
Topics: Adiponectin; Administration, Cutaneous; Aerosols; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemokine CCL22; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Interleukin-17; Male; Middle Aged; Psoriasis; Treatment Outcome | 2018 |
Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Calcium; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Incidence; Japan; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Treatment Outcome | 2018 |
Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.
Topics: Adalimumab; Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Lymphocytosis; Lymphopenia; Male; Middle Aged; Ointments; Psoriasis; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Th17 Cells; Ultraviolet Therapy | 2018 |
A cost-effectiveness analysis of calcipotriol plus betamethasone dipropionate aerosol foam versus gel for the topical treatment of plaque psoriasis.
Topics: Aerosols; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Humans; Ointments; Psoriasis; Quality-Adjusted Life Years | 2018 |
Diphenylcyclopropenone-induced psoriatic koebnerization.
Topics: Academic Medical Centers; Administration, Cutaneous; Betamethasone; Buttocks; Cryotherapy; Cyclopropanes; Follow-Up Studies; Humans; Male; Middle Aged; Psoriasis; Risk Assessment; Skin Diseases; Treatment Outcome; Warts | 2018 |
Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents; Antioxidants; Betamethasone; Cell Death; Cell Line; Cell Survival; Disease Models, Animal; Drug Compounding; Drug Liberation; Ear; Edema; Humans; Imiquimod; Inflammation; Keratinocytes; Lipids; Mice, Inbred BALB C; Nanoparticles; Particle Size; Permeability; Psoriasis; Rheology; Skin; Sus scrofa; Thymol | 2018 |
Prospective, Observational, Non-Interventional, Multicentre Study on the Efficacy and Tolerability of a New Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients with Plaque Psoriasis under Daily Practice Conditions.
Topics: Adult; Aerosols; Aged; Anti-Inflammatory Agents; Betamethasone; Body Surface Area; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome | 2017 |
Response to 'Psoriasis patients' preference for an aerosol foam topical formulation' by Vender R et al.
Topics: Aerosols; Betamethasone; Humans; Patient Preference; Psoriasis | 2018 |
Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque Psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Self Report; Treatment Outcome; Young Adult | 2018 |
Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison.
Topics: Acitretin; Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Esters; Female; Fumarates; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Thalidomide; Treatment Outcome | 2019 |
Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Calcitriol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Combinations; Dyssomnias; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pruritus; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Visual Analog Scale | 2019 |
A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Clinical Decision-Making; Clinical Trials, Phase II as Topic; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Dermatologic Agents; Disease Progression; Drug Compounding; Drug Costs; Glucocorticoids; Humans; Models, Economic; Office Visits; Ointments; Phototherapy; Psoriasis; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sweden; Time Factors; Treatment Outcome | 2019 |
Sociodemographic factors do not have a large influence on adherence to topical treatment in patients with psoriasis.
Topics: Administration, Cutaneous; Age Factors; Betamethasone; Calcitriol; Denmark; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Medication Adherence; Middle Aged; Psoriasis; Self Report; Severity of Illness Index; Sex Factors; Socioeconomic Factors | 2019 |
Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
Topics: Administration, Topical; Adult; Aerosols; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Hand; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Prospective Studies; Psoriasis; Severity of Illness Index; Young Adult | 2019 |
Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2019 |
Patient and Physician Satisfaction with Calcipotriol and Betamethasone Dipropionate Aerosol Foam in the Treatment of Plaque Psoriasis on the Body.
Topics: Aerosols; Anti-Inflammatory Agents; Betamethasone; Cross-Sectional Studies; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Personal Satisfaction; Psoriasis; Retrospective Studies | 2019 |
Whole field laser Doppler imaging of the microcirculation in psoriasis and clinically unaffected skin.
Topics: Aged; Betamethasone; Calcitriol; Dermatologic Agents; Female; Heart Rate; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Pilot Projects; Psoriasis; Skin; Treatment Outcome | 2014 |
Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cell Differentiation; Cell Proliferation; Dermatologic Agents; Disease Models, Animal; Female; Fingolimod Hydrochloride; Humans; Imiquimod; Keratinocytes; Local Lymph Node Assay; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, SCID; Propylene Glycols; Psoriasis; Receptors, Lysosphingolipid; Skin; Skin Transplantation; Sphingosine; Sphingosine-1-Phosphate Receptors; Time Factors | 2013 |
[Pustular psoriasis localized to the genital region].
Topics: Adult; Betamethasone; Biopsy; Dermatomycoses; Desonide; Diagnostic Errors; Herpes Genitalis; Humans; Immunosuppressive Agents; Male; Penile Diseases; Propylene Glycol; Psoriasis; Recurrence | 2013 |
Nail psoriasis masqueraded by secondary infection with Rhodotorula mucilaginosa.
Topics: Acitretin; Adult; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Calcitriol; Coinfection; Dermatologic Agents; Humans; Itraconazole; Keratolytic Agents; Male; Microbiological Techniques; Molecular Diagnostic Techniques; Nails; Onychomycosis; Psoriasis; Rhodotorula; Treatment Outcome | 2013 |
The impact of topical calcipotriol and betamethasone on human beta-defensin 2 expression and serum level in psoriatic patients.
Topics: Adult; Betamethasone; Calcitriol; Defensins; Humans; Middle Aged; Psoriasis | 2013 |
Patterns of vitamin D analog use for the treatment of psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Cross-Sectional Studies; Dermatologic Agents; Female; Glucocorticoids; Health Care Surveys; Humans; Male; Practice Patterns, Physicians'; Psoriasis; Time Factors; United States; Vitamin D | 2013 |
The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis.
Topics: Administration, Cutaneous; Animals; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Psoriasis; Vitamin D | 2013 |
Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
Topics: Adolescent; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Scalp Dermatoses; Young Adult | 2013 |
Clarithromycin induced psoriasis in a 37-year old man.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Clarithromycin; Drug Eruptions; Humans; Male; Psoriasis; Skin | 2014 |
Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
Topics: Adolescent; Adult; Aged; Betamethasone; Calcitriol; Drug Administration Schedule; Female; Gels; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Psoriasis; Quality of Life; Young Adult | 2014 |
Prescription size and adherence in the management of psoriasis: is the more, the better?
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Attitude of Health Personnel; Betamethasone; Calcitriol; Clobetasol; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Drug Prescriptions; Gels; Humans; Immunosuppressive Agents; Medication Adherence; Practice Patterns, Physicians'; Psoriasis | 2014 |
Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
Topics: Adolescent; Betamethasone; Calcitriol; Child; Child, Preschool; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Ointments; Prospective Studies; Psoriasis; Quality of Life; Treatment Outcome | 2014 |
Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Ointments; Pharmacovigilance; Product Surveillance, Postmarketing; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2014 |
Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
Topics: Administration, Cutaneous; Adrenal Insufficiency; Adult; Betamethasone; Chronic Disease; Cushing Syndrome; Dermatitis, Atopic; Glucocorticoids; Humans; Male; Psoriasis; Self Medication; Time Factors; Young Adult | 2014 |
Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice.
Topics: Administration, Topical; Adrenal Cortex Hormones; Betamethasone; Calcitriol; Cholecalciferol; Clinical Trials as Topic; Drug Combinations; Evidence-Based Medicine; Guideline Adherence; Humans; Long-Term Care; Psoriasis | 2014 |
Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis.
Topics: Administration, Topical; Animals; Betamethasone; Calcitriol; Cell Line; Cell Proliferation; Dermis; Diglycerides; Drug Carriers; Drug Combinations; Drug Evaluation, Preclinical; Drug Stability; Epidermis; Gels; Humans; Mice, Inbred BALB C; Nanoparticles; Psoriasis; Rats, Sprague-Dawley; Solubility | 2014 |
Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Dermatology; Drug Combinations; Evidence-Based Medicine; Humans; Psoriasis; Suspensions; Treatment Outcome | 2014 |
Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Child; Child, Preschool; Drug Combinations; Female; Humans; Male; Prospective Studies; Psoriasis; Quality of Life; Scalp Dermatoses; Severity of Illness Index | 2015 |
Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
Topics: Adalimumab; Administration, Topical; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betamethasone; Biopsy; Calcitriol; CD4-Positive T-Lymphocytes; Female; Forkhead Transcription Factors; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Ointments; Psoriasis; Skin; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 2015 |
Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
Topics: Administration, Cutaneous; Attitude of Health Personnel; Betamethasone; Calcitriol; Dermatologic Agents; Dermatology; Drug Combinations; Glucocorticoids; Health Care Surveys; Humans; Italy; Medication Adherence; Practice Patterns, Physicians'; Psoriasis; Quality of Life | 2015 |
Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Pruritus; Psoriasis; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Suspensions; Treatment Outcome | 2014 |
A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.
Topics: Aerosols; Betamethasone; Calcitriol; Calcium; Dermatologic Agents; Drug Combinations; Female; Homeostasis; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Psoriasis | 2016 |
Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Medication Adherence; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Psoriasis; Quality of Life; Severity of Illness Index; Time Factors; Young Adult | 2015 |
Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Emulsions; Female; Glucocorticoids; Humans; Male; Middle Aged; Mometasone Furoate; Patient Acceptance of Health Care; Patient Compliance; Patient Preference; Prospective Studies; Psoriasis; Quality of Life; Scalp Dermatoses | 2016 |
Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Topics: Adrenal Cortex Hormones; Betamethasone; Calcitriol; Cell Communication; Cell Differentiation; Cells, Cultured; Cytokines; Drug Therapy, Combination; Gene Expression Regulation; Humans; Immunologic Factors; Inflammation Mediators; Keratinocytes; Langerhans Cells; Phenotype; Psoriasis; Receptors, Calcitriol; Signal Transduction; Th17 Cells; Tissue Culture Techniques | 2016 |
[Topical psoriasis therapy becomes more tolerable].
Topics: Administration, Topical; Betamethasone; Calcitriol; Drug Combinations; Gels; Humans; Psoriasis | 2016 |
Use of biologics for pustulotic arthro-osteitis in two patients with palmoplantar pustulosis.
Topics: Adalimumab; Adult; Antirheumatic Agents; Arthritis, Psoriatic; Betamethasone; Biological Products; Biopsy; Bone Marrow; Female; Finger Joint; Humans; Infliximab; Magnetic Resonance Imaging; Middle Aged; Osteitis; Psoriasis; Radionuclide Imaging; Skin; Sternum; Technetium; Treatment Outcome | 2017 |
Case of de novo psoriasis possibly triggered by nivolumab.
Topics: Administration, Cutaneous; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Betamethasone; Calcitriol; Drug Combinations; Humans; Male; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Nivolumab; Programmed Cell Death 1 Receptor; Psoriasis; Signal Transduction; Th1 Cells; Th17 Cells | 2017 |
Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.
Topics: Adolescent; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Gels; Greece; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Psoriasis; Quality of Life; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2016 |
Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents; Betamethasone; Cytokines; Disease Models, Animal; Female; Imiquimod; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Psoriasis; RNA, Messenger; Skin; Th1 Cells; Th17 Cells | 2016 |
Steroid swapping between friends: adrenal suppression secondary to psoriasis treatment.
Topics: Acitretin; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Friends; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Prescription Drugs; Psoriasis | 2009 |
Lichen planopilaris and psoriasis.
Topics: Adult; Alopecia; Betamethasone; Cyclosporine; Drug Therapy, Combination; Epidermis; Female; Granulocytes; Humans; Lichen Planus; Lymphocytes; Plasma Cells; Pruritus; Psoriasis; Scalp Dermatoses | 2008 |
Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions.
Topics: Anthralin; Betamethasone; Dermatologic Agents; Female; Glucocorticoids; Humans; Psoriasis; Young Adult | 2009 |
[Update of the topical treatment of psoriasis].
Topics: Administration, Topical; Betamethasone; Calcitriol; Drug Therapy, Combination; Humans; Psoriasis | 2009 |
Generalized pustular psoriasis (von Zumbusch) following the use of calcipotriol and betamethasone dipropionate ointment: a report of two cases.
Topics: Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Eruptions; Female; Humans; Middle Aged; Psoriasis | 2009 |
Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Gels; Humans; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2009 |
Iatrogenic adrenal insufficiency associated with calcipotriol-betamethasone topical combination in psoriasis.
Topics: Adrenal Insufficiency; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Psoriasis | 2010 |
Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Topics: Adiponectin; Adult; Betamethasone; Biomarkers; C-Reactive Protein; Calcitriol; Cardiovascular Diseases; Combined Modality Therapy; Dermatologic Agents; Follow-Up Studies; Glucocorticoids; Humans; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Middle Aged; Oxidative Stress; Psoriasis; PUVA Therapy; Risk Factors; Severity of Illness Index; Ultraviolet Therapy | 2010 |
Circulating Th17 cell fluctuation in psoriatic patients treated with topical calcipotriol and betamethasone butyrate propionate.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psoriasis; Th17 Cells; Treatment Outcome | 2011 |
Guttate psoriasis occurring on varicella lesions.
Topics: Betamethasone; Chickenpox; Child, Preschool; Erythromycin; Humans; Male; Psoriasis; Tacrolimus; Treatment Outcome | 2010 |
The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2011 |
In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; Disease Models, Animal; Drug Therapy, Combination; Epidermis; Fish Oils; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Proteins; Psoriasis; Salicylic Acid; Staining and Labeling; Tomography, Optical Coherence; Treatment Outcome | 2011 |
Effective treatment and improvement of quality of life in patients with scalp psoriasis by topical use of calcipotriol/betamethasone (Xamiol®-gel): results.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Cohort Studies; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Quality of Life; Scalp Dermatoses; Surveys and Questionnaires | 2011 |
Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
Topics: Adult; Betamethasone; Calcitriol; Cross-Sectional Studies; Dermatologic Agents; Erythroid Cells; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neutrophil Activation; Oxidative Stress; Photochemotherapy; Psoriasis; Ultraviolet Therapy | 2012 |
Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Combinations; Drug Compounding; Female; Gels; Humans; Male; Ointments; Psoriasis; Scalp; Treatment Outcome; Young Adult | 2013 |
Linear psoriasis.
Topics: Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Diagnosis, Differential; Drug Combinations; Humans; Male; Psoriasis; Skin Diseases | 2012 |
A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Child; Child, Preschool; Dermatitis, Atopic; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Infant; Male; Psoriasis; Ultraviolet Therapy | 2012 |
Trends in older adult psoriasis outpatient health care practices in the United States.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Betamethasone; Calcitriol; Clobetasol; Coal Tar; Dermatologic Agents; Dermatology; Etanercept; Family Practice; Female; Fluocinolone Acetonide; Glucocorticoids; Health Care Surveys; Humans; Immunoglobulin G; Immunologic Factors; Internal Medicine; Keratolytic Agents; Male; Middle Aged; Practice Patterns, Physicians'; Psoriasis; Receptors, Tumor Necrosis Factor; United States; Young Adult | 2012 |
Letter: Alopecia areata during ustekinumab administration: Co-existence or an adverse reaction?
Topics: Alopecia Areata; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Clobetasol; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome; Ustekinumab | 2012 |
Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Gels; Humans; Psoriasis; Quality of Life; Scalp Dermatoses; Time Factors | 2012 |
Role of VEGF receptors in normal and psoriatic human keratinocytes: evidence from irradiation with different UV sources.
Topics: Adult; Betamethasone; Cell Survival; Enzyme Activation; Epidermis; Female; Gene Expression; Humans; Keratinocytes; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuropilin-1; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-akt; Psoriasis; Receptors, Vascular Endothelial Growth Factor; src-Family Kinases; Ultraviolet Rays; Ultraviolet Therapy; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Young Adult | 2013 |
[New ointment with vitamin D derivative and corticoid. Psoriasis therapy combined].
Topics: Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Humans; Ointments; Psoriasis | 2003 |
Extensive striae distensae as a result of topical corticosteroid therapy in psoriasis vulgaris.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Betamethasone; Female; Glucocorticoids; Humans; Psoriasis; Skin | 2003 |
[THE PROBLEM OF SIDE-EFFECTS IN ADRENAL CORTEX HORMONE TREATMENT OF SKIN DISEASES].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Alopecia Areata; Betamethasone; Dermatitis, Exfoliative; Dermatology; Dexamethasone; Edema; Emaciation; Hypertension; Japan; Obesity; Paramethasone; Psoriasis; Statistics as Topic; Toxicology; Triamcinolone | 1963 |
TOPICAL ACTIVITIES OF BETAMETHASONE ESTERS IN MAN.
Topics: Adrenal Cortex Hormones; Betamethasone; Biomedical Research; Blood Vessels; Esters; Fluocinolone Acetonide; Humans; Male; Metabolism; Pharmacology; Psoriasis; Skin | 1964 |
BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID.
Topics: Adrenal Cortex Hormones; Betamethasone; Betamethasone Valerate; Biomedical Research; Dermatitis; Dermatitis, Atopic; Eczema; Fluocinolone Acetonide; Humans; Hydrocortisone; Ointments; Pharmacology; Psoriasis; Toxicology; Triamcinolone Acetonide | 1964 |
[CLINICAL INVESTIGATION WITH INJECTABLE BETAMETHASONE].
Topics: Betamethasone; Dermatitis, Contact; Dermatology; Drug Eruptions; Drug Hypersensitivity; Histamine H1 Antagonists; Hypersensitivity; Injections; Insect Bites and Stings; Neurodermatitis; Pemphigus; Penicillins; Psoriasis; Toxicology; Urticaria | 1963 |
BETAMETHASONE 17-VALERATE: A CLINICAL TRIAL OF A NEW TOPICAL STEROID.
Topics: Adrenal Cortex Hormones; Betamethasone; Betamethasone Valerate; Biomedical Research; Dermatology; Drug Therapy; Eczema; Fluocinolone Acetonide; Humans; Ointments; Psoriasis; Toxicology | 1964 |
DOUBLE-BLIND COMPARATIVE TRIAL OF BETAMETHASONE 17-VALERATE AND FLUOCINOLONE ACETONIDE OINTMENTS.
Topics: Adrenal Cortex Hormones; Betamethasone; Betamethasone Valerate; Biomedical Research; Dermatology; Double-Blind Method; Drug Therapy; Eczema; Fluocinolone Acetonide; Humans; Ointments; Psoriasis; Toxicology | 1964 |
[CHRONIC ACRODERMATITIS CONTINUA OF HALLOPEAU WITH ERYTHEMATO-SQUAMOUS LOCALIZATIONS OF THE SKIN FOLDS. "CLAW HAND" DEFORMITY. FAVORABLE EFFECT OF A CORTICOID-ANTIBIOTIC ASSOCIATION].
Topics: Acrodermatitis; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Betamethasone; Dermatologic Agents; Drug Therapy; Geriatrics; Hand Deformities; Hoof and Claw; Humans; Psoriasis | 1964 |
PRELIMINARY OBSERVATIONS ON TOPICAL USE OF BETAMETHASONE 17-VALERATE IN PSORIASIS AND IN A FEW OTHER DERMATOLOGICAL DISORDERS.
Topics: Administration, Topical; Betamethasone; Betamethasone Valerate; Drug Therapy; Humans; Psoriasis; Skin Diseases | 1964 |
BETAMETHASONE CREAM IN DERMATOLOGY: A STUDY OF 285 CASES.
Topics: Alopecia; Alopecia Areata; Betamethasone; Dermatology; Drug Therapy; Humans; Ointments; Psoriasis; Research; Skin Diseases | 1965 |
Coexistence of psoriasis and pemphigus after enalapril intake.
Topics: Administration, Topical; Aged; Betamethasone; Enalapril; Follow-Up Studies; Humans; Hypertension; Male; Pemphigus; Psoriasis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Once daily application of a combination of calcipotriol and betamethasone dipropionate (Dovobet, Daivobet) for the treatment of psoriasis.
Topics: Adult; Betamethasone; Calcitriol; Confidence Intervals; Data Interpretation, Statistical; Dermatologic Agents; Double-Blind Method; Drug Combinations; Humans; Multicenter Studies as Topic; Patient Compliance; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Time Factors | 2003 |
Glaucoma from topical corticosteroids to the eyelids.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Blepharitis; Dermatitis, Allergic Contact; Eyelids; Glaucoma; Glucocorticoids; Humans; Hydrocortisone; Intraocular Pressure; Male; Middle Aged; Mometasone Furoate; Pregnadienediols; Psoriasis | 2004 |
[Daivobet: new therapeutic management for psoriasis. Introduction].
Topics: Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Humans; Ointments; Psoriasis; Treatment Outcome | 2004 |
[Daivobet: from concept to medication].
Topics: Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Design; Humans; Placebos; Psoriasis; Treatment Outcome | 2004 |
Bioavailability of betamethasone dipropionate when combined with calcipotriol.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Biological Availability; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Interactions; Humans; Male; Middle Aged; Pilot Projects; Psoriasis | 2004 |
[How I treat ...scalp psoriasis].
Topics: Betamethasone; Humans; Psoriasis; Scalp Dermatoses | 2004 |
Once daily vs. twice daily applications of topical treatments in psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Humans; Psoriasis | 2005 |
[Diffuse retinal pigment epitheliopathy and corticoid ointment topical treatment in a patient with psoriasis].
Topics: Administration, Topical; Betamethasone; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Pigment Epithelium of Eye; Psoriasis; Retinal Diseases | 2005 |
Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Ointments; Psoriasis | 2005 |
Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.
Topics: Adult; Betamethasone; Calcitriol; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 2006 |
Iterative wound dehiscence in augmentation mammaplasty as a systemic side effect of hidden topical corticotherapy.
Topics: Administration, Cutaneous; Adult; Betamethasone; Breast Implantation; Female; Humans; Immunosuppressive Agents; Psoriasis; Recurrence; Surgical Wound Dehiscence | 2006 |
A betamethasone-calcipotriene combination for psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Humans; Psoriasis | 2006 |
Generalized pustular psoriasis complicated by acute respiratory distress syndrome.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Male; Middle Aged; Psoriasis; Respiratory Distress Syndrome | 2006 |
Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2007 |
Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
Topics: Anti-Inflammatory Agents; Betamethasone; Biological Products; Calcitriol; Dermatologic Agents; Drug Administration Routes; Humans; Psoriasis; Severity of Illness Index; Skin Diseases; Treatment Outcome | 2007 |
Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Antigens, CD; Betamethasone; Biopsy; Calcitriol; Cell Proliferation; Dermatologic Agents; Drug Therapy, Combination; Epidermis; Female; Humans; Keratinocytes; Low-Level Light Therapy; Male; Ointments; Psoriasis; Skin; T-Lymphocytes; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Treatment Outcome | 2007 |
Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris.
Topics: Administration, Topical; Adrenal Cortex Hormones; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Ointments; Psoriasis | 2007 |
Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study.
Topics: Betamethasone; Calcitriol; Drug Combinations; Humans; Multicenter Studies as Topic; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic | 2007 |
Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality-Adjusted Life Years; Scotland; State Medicine; Treatment Outcome | 2007 |
Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
Topics: Adult; Betamethasone; Cell Proliferation; Cells, Cultured; Cholecalciferol; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Enterotoxins; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukins; Lymphocyte Activation; Lymphocytes; Male; Mitogens; Psoriasis; Streptococcus; Superantigens; Tumor Necrosis Factor-alpha | 2007 |
Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
Topics: Acrodermatitis; Administration, Topical; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Psoriasis; Skin | 2007 |
Clinical pitfalls: a painful nail enlargement.
Topics: Betamethasone; Calcitriol; Female; Humans; Middle Aged; Nail Diseases; Psoriasis; Ultrasonography | 2008 |
Bilateral periocular psoriasis: an initial manifestation of acute generalized pustular psoriasis with coexistent Sjögren's syndrome.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adult; Betamethasone; Drug Therapy, Combination; Eyelid Diseases; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Orbital Diseases; Prednisolone; Psoriasis; Sjogren's Syndrome | 2007 |
Fluocortolone.
Topics: Betamethasone; Humans; Psoriasis | 1967 |
Proliferative responses of fibroblasts from psoriatic and normal skin to clobetasol propionate.
Topics: Betamethasone; Cell Division; Cells, Cultured; Clobetasol; Fibroblasts; Humans; Male; Psoriasis | 1983 |
The effects of potent topical corticosteroids on adrenocortical function.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex; Adult; Anti-Inflammatory Agents; Betamethasone; Budesonide; Clobetasol; Diflucortolone; Dose-Response Relationship, Drug; Eczema; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Pregnenediones; Psoriasis | 1983 |
[Dermovate scalp application in dermatology. A multi-centre Swiss study (author's transl)].
Topics: Adolescent; Adult; Alopecia; Betamethasone; Child; Child, Preschool; Clobetasol; Dermatitis, Seborrheic; Female; Humans; Male; Middle Aged; Neurodermatitis; Pharmaceutical Vehicles; Pityriasis; Psoriasis; Scalp Dermatoses; Switzerland | 1980 |
[Emovate in dermatological practice].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Clobetasol; Eczema; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Skin Diseases | 1984 |
Metabolic changes in the psoriatic lesion during therapy.
Topics: Acid Phosphatase; Alkaline Phosphatase; Betamethasone; Clobetasol; Epidermis; Glucosephosphate Dehydrogenase; Humans; Photochemotherapy; Psoriasis; PUVA Therapy; Time Factors | 1984 |
Clobetasol propionate for PUVA overdosage.
Topics: Adult; Betamethasone; Clobetasol; Humans; Male; Photochemotherapy; Psoriasis; PUVA Therapy | 1984 |
Diprolene cream in the treatment of severe or resistant corticosteroid-responsive dermatoses.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Atopic; Drug Administration Schedule; Drug Tolerance; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1984 |
Treatment of severe or resistant corticosteroid-responsive dermatoses with Diprolene cream.
Topics: Adult; Aged; Betamethasone; Dermatitis, Atopic; Drug Resistance; Female; Humans; Male; Middle Aged; Ointments; Propylene Glycols; Psoriasis; Skin Diseases | 1984 |
Plasma cortisol studies with 0.05% halometasone cream and ointment in patients with psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis | 1983 |
Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Eczema; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Skin Diseases | 1983 |
Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Eczema; Female; Humans; Hydrocortisone; Kinetics; Male; Middle Aged; Ointments; Psoriasis; Radioimmunoassay | 1983 |
[Kaposi's sarcoma during local and general steroid therapy for psoriasis (author's transl)].
Topics: Aged; Betamethasone; Bone Neoplasms; Fluocinolone Acetonide; Humans; Male; Psoriasis; Sarcoma, Kaposi | 1981 |
Efficacy and tolerance of betamethasone dipropionate propylene glycol for resistant psoriasis and other resistant steroid-responsive dermatoses.
Topics: Adolescent; Adult; Aged; Betamethasone; Dermatitis, Atopic; Drug Resistance; Female; Humans; Male; Middle Aged; Prurigo; Psoriasis | 1981 |
Adult-onset celiac disease hidden by chronic steroid therapy for a skin disease.
Topics: Administration, Oral; Adult; Age of Onset; Anti-Inflammatory Agents; Betamethasone; Celiac Disease; Diagnosis, Differential; Humans; Male; Psoriasis | 1995 |
Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Blister; Combined Modality Therapy; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Interleukin-6; Middle Aged; Ointments; Psoriasis; Salicylates; Salicylic Acid; Skin; Tumor Necrosis Factor-alpha; Ultraviolet Therapy | 1994 |
Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Biomarkers; Combined Modality Therapy; Female; Humans; Interleukin-6; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Severity of Illness Index; Ultraviolet Therapy | 1994 |
Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions.
Topics: Betamethasone; Cell Count; Cell Division; Dermatitis; Humans; Immunohistochemistry; Keratosis, Seborrheic; Ki-67 Antigen; Lichen Planus; Male; Neoplasm Proteins; Nuclear Proteins; Psoriasis; Skin; Skin Diseases; Tumor Suppressor Protein p53 | 1994 |
Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Exfoliative; Female; Glucocorticoids; Humans; Male; Middle Aged; Occlusive Dressings; Psoriasis; Time Factors | 1994 |
Novel steroid derivative modulates gene expression of cytokines and growth regulators.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Cells, Cultured; Cytokines; Gene Expression; Humans; Hydrocortisone; Mometasone Furoate; Polymerase Chain Reaction; Pregnadienediols; Psoriasis; Receptors, Cytokine; RNA, Messenger; Steroids | 1995 |
[Pustular psoriasis in pregnancy].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Infant, Newborn; Male; Prednisone; Pregnancy; Pregnancy Complications; Psoriasis; Skin Diseases, Vesiculobullous | 1995 |
[A patient with psoriatic arthritis due to generalized pustular psoriasis (von Zumbusch type)].
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Betamethasone; Humans; Male; Methotrexate; Psoriasis | 1997 |
In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Incompatibility; Fluocinonide; In Vitro Techniques; Mometasone Furoate; Nicotinic Acids; Pregnadienediols; Psoriasis | 2000 |
[UV-B comb versus betamethasone solution in scalp psoriasis].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Evaluation Studies as Topic; Female; Glucocorticoids; Humans; Male; Psoriasis; Scalp Dermatoses; Treatment Outcome; Ultraviolet Therapy | 2000 |
Oral lesions in patients with psoriasis: clinical presentation and management.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Biopsy; Burning Mouth Syndrome; Candidiasis, Oral; Diagnosis, Differential; Follow-Up Studies; Gingiva; Gingival Diseases; Gingival Recession; Glucocorticoids; Humans; Lichen Planus, Oral; Male; Middle Aged; Psoriasis; Tongue, Fissured | 2000 |
Bilateral femoral avascular necrosis in a man with psoriasis: responsibility of topical corticosteroids and role of cyclosporine.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Cyclosporine; Drug Interactions; Femur Head Necrosis; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis | 2001 |
Intermittent treatment of psoriasis with clobetasol propionate.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Clobetasol; Female; Humans; Male; Middle Aged; Psoriasis | 1978 |
Systemic effects of local treatment with high doses of potent corticosteroids in psoriatics.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Betamethasone; Clobetasol; Cushing Syndrome; Desoximetasone; Female; Flumethasone; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1979 |
Hazards of steroid therapy in hepatic failure.
Topics: Acute Disease; Addison Disease; Adrenal Cortex Hormones; Betamethasone; Dermatitis, Exfoliative; Eczema; Humans; Liver Diseases; Middle Aged; Psoriasis; Skin Diseases | 1975 |
Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis.
Topics: Aged; Betamethasone; Chronic Disease; Drug Eruptions; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Time Factors | 1976 |
Dermatologic investigation of betamethasone 17,21-dipropionate ointment with chinoform.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Clioquinol; Dermatitis; Drug Combinations; Drug Evaluation; Eczema; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1977 |
Psoriatic therapeutics and glucose-6-phosphate dehydrogenase.
Topics: Animals; Betamethasone; Cattle; Cyclic GMP; Drug Evaluation, Preclinical; Folic Acid; Glucosephosphate Dehydrogenase; Guinea Pigs; Kinetics; Methotrexate; Psoriasis | 1975 |
Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate.
Topics: Administration, Topical; Adrenocorticotropic Hormone; Betamethasone; Female; Humans; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Psoriasis | 1979 |
Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
Topics: Administration, Topical; Adolescent; Adult; Aged; Beclomethasone; Betamethasone; Betamethasone Valerate; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Ointments; Psoriasis | 1979 |
[Comparative study of 2 topical steroids preparations: desoximetasone and betamethasone dipropionate].
Topics: Administration, Topical; Adult; Aged; Betamethasone; Desoximetasone; Dexamethasone; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis | 1978 |
Managing chronic skin conditions with two differing topical corticosteroids.
Topics: Administration, Topical; Betamethasone; Butyrates; Chronic Disease; Clobetasol; Drug Evaluation; Eczema; Humans; Patient Education as Topic; Propionates; Psoriasis | 1979 |
[A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
Topics: Betamethasone; Betamethasone Valerate; Cushing Syndrome; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Ointments; Psoriasis | 1978 |
The use of Dermovate in the treatment of psoriasis.
Topics: Betamethasone; Clobetasol; Humans; Psoriasis; Recurrence | 1978 |
An open clinical trial comparing (paired comparisons) desoximetasone with betamethasone 17-valerate.
Topics: Betamethasone; Betamethasone Valerate; Desoximetasone; Dexamethasone; Drug Evaluation; Eczema; Humans; Psoriasis | 1978 |
Penetration of topical steroid preparations.
Topics: Betamethasone; Clobetasol; Humans; Psoriasis; Skin Absorption | 1977 |
Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids.
Topics: Adolescent; Adult; Arachidonic Acids; Betamethasone; Female; Glucocorticoids; Humans; Hydroxy Acids; Male; Psoriasis | 1977 |
Atrophic skin striae following the use of clobetasol propionate ointment.
Topics: Administration, Topical; Adult; Betamethasone; Child; Clobetasol; Female; Humans; Psoriasis; Skin Diseases | 1977 |
Local treatment of psoriasis of the scalp with clobetasol propionate in alcoholic solution: a comparison of once and twice a day application.
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Female; Humans; Male; Middle Aged; Propionates; Psoriasis; Scalp Dermatoses; Time Factors | 1976 |
[Statistical evaluation of Diproderm trials on 2700 patients by dermatologists and general practicians--comprehensive assessment].
Topics: Adult; Aged; Austria; Betamethasone; Drug Evaluation; Eczema; Evaluation Studies as Topic; Family Practice; Female; Humans; Male; Middle Aged; Neurodermatitis; Pruritus; Psoriasis; Skin Diseases; Statistics as Topic | 1976 |
Betamethasone dipropionate: a new topical agent for the treatment of psoriasis.
Topics: Adult; Aged; Betamethasone; Drug Evaluation; Female; Humans; Male; Middle Aged; Psoriasis | 1975 |
Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.
Topics: Betamethasone; Cosyntropin; Cushing Syndrome; Female; Humans; Insulin; Male; Middle Aged; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Psoriasis | 1975 |
Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment.
Topics: Azathioprine; Betamethasone; Female; Humans; Male; Methotrexate; Middle Aged; Ointments; Psoriasis; Steroids, Chlorinated | 1975 |
[Diprosone cream: its value in daily dermatologic practice].
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Cresols; Drug Combinations; Drug Evaluation; Eczema; Glucocorticoids; Humans; Neomycin; Neurodermatitis; Ointments; Parakeratosis; Psoriasis; Skin Diseases | 1975 |
[Betamethasone dipropionate. A dermocorticoid].
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Eczema; Glucocorticoids; Humans; Neomycin; Ointments; Propionates; Pruritus; Psoriasis; Skin Diseases | 1975 |
Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.
Topics: Administration, Topical; Animals; Betamethasone; Clobetasol; Cosyntropin; Eczema; Fluocortolone; Humans; Insulin; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Psoriasis; Skin; Swine | 1975 |
[Comparative studies on Diproderm-cream].
Topics: Administration, Topical; Betamethasone; Drug Evaluation; Female; Fluocinolone Acetonide; Humans; Male; Ointments; Psoriasis; Skin Diseases | 1975 |
Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
Topics: Adolescent; Anthracenes; Anthralin; Betamethasone; Humans; Male; Psoriasis; Remission, Spontaneous | 1976 |
The effect of corticosteroids on cell turnover in the psoriatic patient. A review.
Topics: Adrenal Cortex Hormones; Betamethasone; Betamethasone Valerate; DNA; DNA Repair; Humans; Kinetics; Mitosis; Psoriasis; Skin | 1976 |
Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone; Epidermis; Female; Fluorescent Antibody Technique; Glucocorticoids; Humans; Immunoenzyme Techniques; Keratins; Male; Methoxsalen; Middle Aged; Molecular Weight; Psoriasis; PUVA Therapy; Skin | 1992 |
[Plasma exchange therapy of dermatosis].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Betamethasone; Female; Humans; Middle Aged; Pemphigoid, Bullous; Plasma Exchange; Psoriasis; Scleroderma, Systemic | 1992 |
The finger-tip unit--a new practical measure.
Topics: Administration, Topical; Adult; Betamethasone; Eczema; Female; Fingers; Humans; Male; Ointments; Psoriasis; Sex Factors | 1991 |
Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Betamethasone; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Humans; Middle Aged; Psoriasis; Receptors, Interleukin-2 | 1990 |
[Vipsogal in the therapy of psoriasis].
Topics: Adult; Aged; Betamethasone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fluocinonide; Gentamicins; Humans; Male; Middle Aged; Ointments; Pantothenic Acid; Psoriasis; PUVA Therapy | 1990 |
Induction of ornithine decarboxylase following sellotape stripping in normal and psoriatic skin.
Topics: Adolescent; Adult; Betamethasone; Enzyme Induction; Female; Humans; Indomethacin; Male; Middle Aged; Ornithine Decarboxylase; Psoriasis; Skin; Time Factors | 1990 |
The safety of halobetasol 0.05% ointment in the treatment of psoriasis.
Topics: 17-Hydroxycorticosteroids; Adult; Aged; Betamethasone; Clobetasol; Drug Evaluation; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Psoriasis; Time Factors | 1990 |
Psoriasis treatment with betamethasone dipropionate using short-term application and short-term occlusion.
Topics: Administration, Topical; Betamethasone; Double-Blind Method; Humans; Occlusive Dressings; Psoriasis; Random Allocation; Time Factors | 1986 |
Topical corticosteroids.
Topics: Administration, Topical; Betamethasone; Clobetasol; Eczema; Humans; Psoriasis | 1989 |
Cushing's syndrome, topical steroids, and cling film.
Topics: Administration, Topical; Betamethasone; Clobetasol; Cushing Syndrome; Female; Humans; Middle Aged; Ointments; Psoriasis | 1986 |
[Clinical and experimental studies on blood histamine levels in topical corticosteroid therapy].
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Betamethasone; Betamethasone Valerate; Budesonide; Dermatitis, Exfoliative; Female; Histamine; Humans; Leukocyte Count; Male; Middle Aged; Ointments; Pregnenediones; Psoriasis | 1987 |
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Betamethasone; Clobetasol; Dinoprostone; Exudates and Transudates; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Male; Middle Aged; Prostaglandins E; Psoriasis; Skin | 1986 |
[Distribution of nuclear DNase in psoriasis vulgaris and its changes after several therapies--a study of immunohistochemistry].
Topics: Administration, Cutaneous; Administration, Oral; Betamethasone; Cell Nucleus; Clobetasol; Deoxyribonucleases; Drug Evaluation; Etretinate; Humans; Immunoenzyme Techniques; Mitosis; Mitotic Index; Psoriasis; PUVA Therapy; Skin | 1988 |
Psoriasiform drug eruption due to glibenclamide.
Topics: Betamethasone; Diabetes Mellitus; Drug Hypersensitivity; Female; Glyburide; Humans; Middle Aged; Psoriasis | 1987 |
The use and abuse of 0.05 per cent clobetasol propionate in dermatology.
Topics: Administration, Topical; Betamethasone; Clobetasol; Eczema; Humans; Psoriasis; Skin Diseases | 1988 |
Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
Topics: Antigen-Presenting Cells; Betamethasone; Betamethasone Valerate; Clobetasol; Fluorescent Antibody Technique; HLA-D Antigens; HLA-DR Antigens; Humans; Langerhans Cells; Psoriasis | 1988 |
Potent topical steroids and psoriasis.
Topics: Administration, Topical; Betamethasone; Clobetasol; Cushing Syndrome; Humans; Male; Middle Aged; Psoriasis | 1988 |
Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis.
Topics: Administration, Oral; Betamethasone; Clobetasol; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Humans; Psoriasis | 1988 |
Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Dexamethasone; Drug Combinations; Eczema; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Psoriasis; Salicylates | 1987 |
Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
Topics: Administration, Topical; Betamethasone; Clobetasol; Humans; Psoriasis | 1987 |
Adrenal suppression following low-dose topical clobetasol propionate.
Topics: Administration, Topical; Adrenal Glands; Adrenal Insufficiency; Adult; Aged; Betamethasone; Clobetasol; Depression, Chemical; Female; Humans; Male; Middle Aged; Psoriasis | 1987 |
Evaluation of treatment with Sicorten cream by day and Sicorten ointment at night in patients with chronic psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Dosage Forms; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1986 |
Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Humans; Hydrocortisone; Psoriasis; Skin; Vasoconstriction | 1986 |
Avascular necrosis of the hips following longterm use of clobetasol propionate.
Topics: Betamethasone; Clobetasol; Femur Head Necrosis; Humans; Male; Middle Aged; Psoriasis | 1986 |
[Topical treatment of glucocorticoid-sensitive dermatoses with diflorasone diacetate].
Topics: Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Child; Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Female; Humans; Male; Middle Aged; Psoriasis; Skin | 1986 |
Transepidermal elimination following the use of a topical adrenal steroid.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Female; Glucocorticoids; Humans; Psoriasis; Skin | 1985 |
Clinical experience with 0.05% clobetasol propionate creams.
Topics: Adult; Betamethasone; Clobetasol; Eczema; Humans; Male; Psoriasis | 1985 |
Diflorasone diacetate ointment 0.05 percent in conjunction with UVB and tar in a modified outpatient Goeckerman regimen.
Topics: Administration, Topical; Adult; Aged; Baths; Betamethasone; Coal Tar; Combined Modality Therapy; Humans; Middle Aged; Ointments; Outpatients; Patient Compliance; Psoriasis; Ultraviolet Therapy | 1985 |
Cytoplasmic and mitochondrial isoenzymes of malatedehydrogenase in psoriatic epidermis.
Topics: Anthracenes; Betamethasone; Cytoplasm; Electrophoresis, Disc; Humans; Isoenzymes; Malate Dehydrogenase; Mitochondria; Psoriasis; Skin; Ultrasonics | 1971 |
Plethysmographic recordings of skin pulses. 3. Effect of corticosteroids, dithranol and tar in psoriasis.
Topics: Adult; Anthracenes; Betamethasone; Humans; Hydrocortisone; Middle Aged; Occlusive Dressings; Plethysmography; Psoriasis; Pulse; Regional Blood Flow; Skin; Tars | 1971 |
Pituitary-adrenal function after topical steroids.
Topics: Betamethasone; Female; Humans; Middle Aged; Ointments; Pituitary-Adrenal System; Psoriasis | 1967 |
Plethysmographic recordings of skin pulses with particular reference to the piezoelectric method. I. Preliminary report.
Topics: Betamethasone; Electricity; Extremities; Female; Humans; Hyperemia; Leg Ulcer; Male; Methods; Plethysmography; Pressure; Psoriasis; Pulse; Regional Blood Flow; Skin; Skin Physiological Phenomena; Vasoconstrictor Agents | 1970 |
Effect of long-acting parenteral corticosteroids on adrenal function.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adult; Aged; Betamethasone; Dermatitis, Exfoliative; Female; Humans; Hydrocortisone; Injections, Intramuscular; Male; Middle Aged; Pituitary-Adrenal System; Psoriasis; Triamcinolone; Triamcinolone Acetonide | 1969 |
[The association of betamethasone valerianate and gentamicin sulfate in the treatment of inflammatory dermatoses].
Topics: Acne Vulgaris; Betamethasone; Dermatitis, Contact; Eczema; Gentamicins; Humans; Impetigo; Pemphigus; Psoriasis; Skin Diseases | 1968 |
Recent advances in dermatology.
Topics: 17-Ketosteroids; Acne Vulgaris; Adrenal Cortex Hormones; Anti-Bacterial Agents; Betamethasone; Dermatitis; Fludrocortisone; Humans; Hydrocortisone; Intestinal Diseases; Intestine, Small; Ointments; Prednisolone; Psoriasis; Skin Diseases; Tetracycline | 1970 |
[The effectiveness of local corticosteroid treatment for patients with various dermatoses].
Topics: Adolescent; Adult; Aged; Betamethasone; Dermatitis; Dermatologic Agents; Eczema; Female; Glucocorticoids; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Male; Middle Aged; Neurodermatitis; Ointments; Psoriasis; Rosacea; Skin Diseases | 1971 |
Pseudo-atrophy due to locally applied steroids.
Topics: Adolescent; Betamethasone; Dermatitis, Contact; Drug Eruptions; Female; Humans; Psoriasis | 1971 |
The use of a new topical steroid in general practice.
Topics: Administration, Topical; Aged; Betamethasone; Dermatitis, Seborrheic; Eczema; Family Practice; Female; Humans; Male; Middle Aged; Occlusive Dressings; Protective Clothing; Psoriasis; Remission, Spontaneous | 1974 |
Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Age Factors; Aged; Betamethasone; Dexamethasone; Female; Folic Acid Antagonists; Humans; Hydrocortisone; Male; Methotrexate; Middle Aged; Paramethasone; Prednisolone; Prognosis; Psoriasis; Triamcinolone | 1969 |
Diseases of the skin. Treatment of scalp disorders.
Topics: Adrenocorticotropic Hormone; Alopecia; Betamethasone; Dermatitis, Seborrheic; Detergents; Eczema; Female; Hair; Hexachlorophene; Humans; Impetigo; Lice Infestations; Lichen Planus; Male; Psoriasis; Pyridinium Compounds; Salicylates; Scalp Dermatoses; Selenium; Skin Neoplasms; Sulfur; Tinea Capitis | 1974 |
[Experience with an oral corticoid-antihistaminic combination in dermatological practice].
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Child, Preschool; Dermatitis, Contact; Dermatitis, Occupational; Dermatomycoses; Eczema; Erythema; Exanthema; Female; Histamine H1 Antagonists; Humans; Hypersensitivity, Delayed; Male; Middle Aged; Pityriasis; Pruritus; Psoriasis; Rosacea; Skin Diseases | 1968 |
[Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)].
Topics: Betamethasone; Drug Evaluation, Preclinical; Fluocinolone Acetonide; Glucocorticoids; Glucosephosphate Dehydrogenase; Humans; Hydrocortisone; Methylprednisolone; Psoriasis; Skin; Triamcinolone Acetonide | 1974 |
Pustular psoriasis with adrenal suppression following topical corticosteroids.
Topics: Administration, Topical; Adrenal Insufficiency; Anthracenes; Anti-Inflammatory Agents; Betamethasone; Female; Glucocorticoids; Humans; Middle Aged; Nephrectomy; Pregnadienediols; Psoriasis | 1974 |
The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionate.
Topics: Administration, Topical; Adrenal Glands; Adult; Aged; Betamethasone; Eczema; Female; Humans; Lichen Planus; Male; Middle Aged; Psoriasis; Steroids, Chlorinated | 1974 |
Psoriasis: its nature and treatment.
Topics: Adrenal Cortex Hormones; Aminopterin; Australia; Betamethasone; Diet; Europe; Humans; Methotrexate; Psoriasis; Skin; Triamcinolone Acetonide; Ultraviolet Rays; United Kingdom; United States | 1972 |
Adrenal and pituitary functions during long-term topical steroid therapy.
Topics: 17-Ketosteroids; Administration, Topical; Adrenal Insufficiency; Anti-Inflammatory Agents; Betamethasone; Butyrates; Drug Synergism; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Hypopituitarism; Metyrapone; Middle Aged; Occlusive Dressings; Ointments; Pituitary-Adrenal System; Psoriasis; Time Factors; Triamcinolone Acetonide; Valerates | 1972 |
Problems in selection of topical anti-inflammatory corticosteroids.
Topics: Abdomen; Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Cadaver; Dermatitis, Atopic; Dermatitis, Contact; Humans; Middle Aged; Prednisolone; Psoriasis; Skin Absorption; Triamcinolone Acetonide; Vascular Resistance | 1973 |
Pituitary-adrenal function after prolonged use of topical corticosteroids.
Topics: 11-Hydroxycorticosteroids; Administration, Topical; Adolescent; Adrenal Glands; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Blood Glucose; Child; Eczema; Female; Fluocinolone Acetonide; Humans; Insulin; Male; Middle Aged; Pituitary Gland; Psoriasis; Skin Diseases; Time Factors | 1973 |
A 7-year follow-up study of ninety patients with psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Ambulatory Care; Betamethasone; Female; Follow-Up Studies; Home Nursing; Hospitalization; Humans; Male; Prognosis; Psoriasis; Remission, Spontaneous; Salicylates; Tars; Time Factors; Ultraviolet Therapy | 1974 |
Paravertebral ossification in psoriatic arthritis.
Topics: Adult; Arthritis; Betamethasone; Diagnosis, Differential; Humans; In Vitro Techniques; Lumbosacral Region; Middle Aged; Ossification, Heterotopic; Prednisone; Psoriasis; Radiography; Rheumatoid Factor; Spinal Diseases; Spinal Osteophytosis; Spondylitis, Ankylosing; Thoracic Vertebrae | 1965 |
[Immediate results of the external application of the corticosteroid preparation "Celestoderm-v" in psoriasis].
Topics: Adolescent; Adult; Betamethasone; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Psoriasis | 1972 |
[Studies on the systemic effect of extensively applied topical steroids].
Topics: 17-Hydroxycorticosteroids; Acetates; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Contraceptives, Oral; Eczema; Female; Fluorine; Fluorometry; Fluprednisolone; Glucocorticoids; Humans; Hydroxycorticosteroids; Middle Aged; Prednisolone; Prurigo; Pruritus; Psoriasis; Skin Absorption; Skin Diseases; Urticaria; Valerates | 1972 |
Iatrogenic Cushing's syndrome.
Topics: Adult; Betamethasone; Cushing Syndrome; Female; Humans; Iatrogenic Disease; Psoriasis | 1972 |
Effect of topical betamethasone-17-valerate on collagen biosynthesis in psoriatic skin.
Topics: Adrenal Cortex Hormones; Atrophy; Betamethasone; Biopsy; Carbon Isotopes; Collagen; Humans; Hydroxyproline; Proline; Psoriasis; Skin; Valerates | 1971 |
[Therapy of psoriasis].
Topics: Adrenal Cortex Hormones; Anthraquinones; Betamethasone; Coal Tar; Ergocalciferols; Humans; Mercury; Ointments; ortho-Aminobenzoates; Psoriasis; Salicylates; Sulfur; Triamcinolone | 1970 |
Clinical comparisons between topical steroids in self-penetrating bases.
Topics: Betamethasone; Eczema; Gels; Humans; Ointments; Pregnanes; Psoriasis | 1969 |
The problem of psoriasis.
Topics: Betamethasone; Coal Tar; Humans; Mitosis; Psoriasis | 1970 |
Percutaneous absorption of betamethasone-17-benzoate.
Topics: Adult; Benzoates; Betamethasone; Dermatitis; Female; Humans; Hydrocortisone; Male; Pituitary-Adrenal Function Tests; Psoriasis; Skin | 1970 |
[Experience in using the 2 levels of concentration of Betnevate N cream (betamethasone 17-valerate with Fradiomycin sulfate)].
Topics: Acute Disease; Adult; Aged; Betamethasone; Child; Child, Preschool; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Female; Humans; Infant; Male; Middle Aged; Neomycin; Pregnanetriol; Psoriasis; Skin Diseases; Valerates | 1970 |
[Purpuric striae secondary to the prolonged and extensive application of a cream containing corticoids].
Topics: Adult; Betamethasone; Humans; Male; Ointments; Psoriasis; Purpura | 1967 |
A trial of beclomethasone dipropionate in general practice.
Topics: Betamethasone; Eczema; Humans; Psoriasis | 1968 |
Hyperkeratosis lenticularis perstans (Flegel) or dyskeratotic psoriasiform dermatosis. A single dermatosis or two?
Topics: Adult; Betamethasone; Diagnosis, Differential; Female; Humans; Keratosis; Male; Middle Aged; Psoriasis | 1968 |
[Effect of local corticotherapy on a case of diabetes mellitus].
Topics: Betamethasone; Diabetes Mellitus; Female; Fluocinolone Acetonide; Humans; Hyperglycemia; Middle Aged; Occlusive Dressings; Psoriasis | 1968 |
[Treatment of chronic skin diseases with adhesive occlusive bandages].
Topics: Anti-Bacterial Agents; Betamethasone; Humans; Lichen Planus; Methods; Occlusive Dressings; Ointments; Psoriasis | 1969 |
Betamethasone valerate ointment (Valisone).
Topics: Betamethasone; Eczema; Fluocinolone Acetonide; Humans; Ointments; Psoriasis; Valerates | 1969 |
[The 17-valerate of betamethasone cream in dermatology].
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Child, Preschool; Dermatitis; Female; Humans; Infant; Male; Middle Aged; Neurodermatitis; Psoriasis | 1965 |
[Betamethasone valerate, a new corticoid for topical use in dermatology].
Topics: Betamethasone; Psoriasis; Skin Diseases | 1965 |
Clinical experiences with a potent new corticosteroid ester for dermatoses. Report describing a preliminary clinical study of bethamethasone, a new, active topical corticosteroid.
Topics: Aged; Betamethasone; Female; Humans; Male; Middle Aged; Psoriasis; Skin Diseases | 1966 |
Percutaneous absorption of tritium-labelled betamethasone-17-valerate.
Topics: Betamethasone; Humans; Pemphigus; Psoriasis; Radiometry; Skin Absorption; Tritium | 1966 |
[Enzyme-chemical aspects of antipsoriatic therapy].
Topics: Animals; Betamethasone; Dermatologic Agents; Dexamethasone; Guinea Pigs; Humans; Hydrocortisone; Oxidoreductases; Prednisolone; Psoriasis; Transferases; Triamcinolone | 1966 |
[Studies of the problems of unilateral experiments with local corticoids (betamethasone-17-valerate and flumethasone-pivalate)].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Betamethasone; Female; Flumethasone; Fluorine; Glucocorticoids; Humans; Lichen Planus; Male; Pregnanes; Psoriasis; Skin; Valerates | 1966 |